Transcription	O
mediated	O
by	O
NFAT	B-protein
is	O
highly	O
inducible	O
in	O
effector	O
CD4+	B-cell_type
T	I-cell_type
helper	I-cell_type
2	I-cell_type
(	I-cell_type
Th2	I-cell_type
)	I-cell_type
cells	I-cell_type
but	O
not	O
in	O
Th1	B-cell_type
cells	I-cell_type
.	O

Transcriptional	B-protein
factors	I-protein
of	O
the	O
NFAT	B-protein
family	I-protein
play	O
an	O
important	O
role	O
in	O
regulating	O
the	O
expression	O
of	O
several	O
cytokine	B-DNA
genes	I-DNA
during	O
the	O
immune	O
response	O
,	O
such	O
as	O
the	O
genes	O
for	O
interleukin	B-protein
2	I-protein
(	O
IL-2	B-protein
)	O
and	O
IL-4	B-protein
,	O
among	O
others	O
.	O

Upon	O
antigen	O
stimulation	O
,	O
precursor	O
CD4+	B-cell_type
T	I-cell_type
helper	I-cell_type
(	I-cell_type
pTh	I-cell_type
)	I-cell_type
cells	I-cell_type
proliferate	O
and	O
differentiate	O
into	O
two	O
populations	O
of	O
effector	B-cell_type
cells	I-cell_type
(	O
eTh1	B-cell_type
and	O
eTh2	B-cell_type
)	O
,	O
each	O
one	O
expressing	O
a	O
specific	O
pattern	O
of	O
cytokines	B-protein
that	O
distinguishes	O
them	O
from	O
their	O
precursors	O
.	O

eTh2	B-cell_type
cells	I-cell_type
are	O
the	O
major	O
source	O
of	O
IL-4	B-protein
,	O
while	O
gamma	B-protein
interferon	I-protein
is	O
produced	O
by	O
eTh1	B-cell_type
cells	I-cell_type
.	O

Here	O
we	O
have	O
used	O
reporter	O
transgenic	O
mice	O
to	O
show	O
that	O
DNA	O
binding	O
and	O
transcriptional	O
activities	O
of	O
NFAT	B-protein
are	O
transiently	O
induced	O
during	O
the	O
differentiation	O
of	O
pTh	B-cell_type
cells	I-cell_type
into	O
either	O
eTh1	B-cell_type
or	O
eTh2	B-cell_type
cells	I-cell_type
to	O
mediate	O
the	O
expression	O
of	O
IL-2	B-protein
as	O
a	O
common	O
growth	O
factor	O
in	O
both	O
pathways	O
.	O

However	O
,	O
although	O
NFAT	B-protein
DNA	O
binding	O
is	O
similarly	O
induced	O
in	O
both	O
eTh1	B-cell_type
and	O
eTh2	B-cell_type
cells	I-cell_type
upon	O
antigen	O
stimulation	O
,	O
only	O
the	O
NFAT	B-protein
complexes	I-protein
present	O
in	O
eTh2	B-cell_type
cells	I-cell_type
are	O
able	O
to	O
mediate	O
high-level	O
transcription	O
,	O
and	O
relatively	O
little	O
NFAT	B-protein
transcriptional	O
activity	O
was	O
induced	O
in	O
eTh1	B-cell_type
cells	I-cell_type
.	O

In	O
contrast	O
to	O
activated	O
pTh	B-cell_type
cells	I-cell_type
,	O
neither	O
eTh1	B-cell_type
nor	O
eTh2	B-cell_type
cells	I-cell_type
produced	O
significant	O
IL-2	B-protein
upon	O
stimulation	O
,	O
but	O
the	O
high	O
levels	O
of	O
NFAT	B-protein
transcriptional	O
activities	O
directly	O
correlate	O
with	O
the	O
IL-4	B-protein
production	O
induced	O
in	O
response	O
to	O
antigen	O
stimulation	O
in	O
eTh2	B-cell_type
cells	I-cell_type
.	O

These	O
data	O
suggest	O
that	O
activated	O
NFAT	B-protein
is	O
involved	O
in	O
the	O
effector	O
function	O
of	O
eTh2	B-cell_type
cells	I-cell_type
and	O
that	O
the	O
failure	O
of	O
eTh1	B-cell_type
cells	I-cell_type
to	O
produce	O
IL-4	B-protein
in	O
response	O
to	O
an	O
antigen	O
is	O
due	O
,	O
at	O
least	O
partially	O
,	O
to	O
a	O
failure	O
to	O
induce	O
high-level	O
transcription	O
of	O
the	O
IL-4	B-DNA
gene	I-DNA
by	O
NFAT	B-protein
.	O

Regulation	O
of	O
NFAT	B-protein
could	O
be	O
therefore	O
a	O
critical	O
element	O
in	O
the	O
polarization	O
to	O
eTh1	B-cell_type
or	O
eTh2	B-cell_type
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGYy	NULL
,	NULL
Mar	NULL
.	NULL

1997	NULL
,	NULL
p.	NULL
1522-1534	NULL
0270-7306/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
Â©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

17	NULL
,	NULL
No	NULL
.	NULL

3	NULL
Transcription	NULL
Mediated	NULL
by	NULL
NFAT	NULL
Is	NULL
Highly	NULL
Inducible	NULL
in	NULL
Effector	NULL
CD4*	NULL
T	NULL
Helper	NULL
2	NULL
(	NULL
Th2	NULL
)	NULL
Cells	NULL
but	NULL
Not	NULL
in	NULL
Th1	NULL
Cells	NULL
MERCEDES	NULL
RINCON	NULL
'	NULL
f	NULL
anp	NULL
RICHARD	NULL
A.	NULL
FLAVELL'*	NULL
Section	NULL
of	NULL
Immunobiology	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
and	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
``	NULL
New	NULL
Haven	NULL
,	NULL
Connecticut	NULL
06510	NULL
Received	NULL
9	NULL
September	NULL
1996/Returned	NULL
for	NULL
modification	NULL
29	NULL
October	NULL
1996/Accepted	NULL
19	NULL
December	NULL
1996	NULL
Transcriptional	NULL
factors	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
during	NULL
the	NULL
immune	NULL
response	NULL
,	NULL
such	NULL
as	NULL
the	NULL
genes	NULL
for	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
IL-4	NULL
,	NULL
among	NULL
others	NULL
.	NULL

Upon	NULL
antigen	NULL
stimulation	NULL
,	NULL
precursor	NULL
CD4*	NULL
T	NULL
helper	NULL
(	NULL
pTh	NULL
)	NULL
cells	NULL
proliferate	NULL
and	NULL
differentiate	NULL
into	NULL
two	NULL
populations	NULL
of	NULL
effector	NULL
cells	NULL
(	NULL
eTh1	NULL
and	NULL
eTh2	NULL
)	NULL
,	NULL
each	NULL
one	NULL
expressing	NULL
a	NULL
specific	NULL
pattern	NULL
of	NULL
cytokines	NULL
that	NULL
distinguishes	NULL
them	NULL
from	NULL
their	NULL
precursors	NULL
.	NULL

eTh2	NULL
cells	NULL
are	NULL
the	NULL
major	NULL
source	NULL
of	NULL
IL-4	NULL
,	NULL
while	NULL
gamma	NULL
interferon	NULL
is	NULL
produced	NULL
by	NULL
eTh1	NULL
cells	NULL
.	NULL

Here	NULL
we	NULL
have	NULL
used	NULL
reporter	NULL
transgenic	NULL
mice	NULL
to	NULL
show	NULL
that	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activities	NULL
of	NULL
NFAT	NULL
are	NULL
transiently	NULL
induced	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
pTh	NULL
cells	NULL
into	NULL
either	NULL
eTh1	NULL
or	NULL
eTh2	NULL
cells	NULL
to	NULL
mediate	NULL
the	NULL
expression	NULL
of	NULL
IL-2	NULL
as	NULL
a	NULL
common	NULL
growth	NULL
factor	NULL
in	NULL
both	NULL
pathways	NULL
.	NULL

However	NULL
,	NULL
although	NULL
NFAT	NULL
DNA	NULL
binding	NULL
is	NULL
similarly	NULL
induced	NULL
in	NULL
both	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
upon	NULL
antigen	NULL
stimulation	NULL
,	NULL
only	NULL
the	NULL
NFAT	NULL
complexes	NULL
present	NULL
in	NULL
eTh2	NULL
cells	NULL
are	NULL
able	NULL
to	NULL
mediate	NULL
high-level	NULL
transcription	NULL
,	NULL
and	NULL
relatively	NULL
little	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
was	NULL
induced	NULL
in	NULL
eTh1	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
activated	NULL
pTh	NULL
cells	NULL
,	NULL
neither	NULL
eTh1	NULL
nor	NULL
eTh2	NULL
cells	NULL
produced	NULL
significant	NULL
IL-2	NULL
upon	NULL
stimulation	NULL
,	NULL
but	NULL
the	NULL
high	NULL
levels	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activities	NULL
directly	NULL
correlate	NULL
with	NULL
the	NULL
IL-4	NULL
production	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
stimulation	NULL
in	NULL
eTh2	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
activated	NULL
NFAT	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
effector	NULL
function	NULL
of	NULL
eTh2	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
failure	NULL
of	NULL
eTh1	NULL
cells	NULL
to	NULL
produce	NULL
IL-4	NULL
in	NULL
response	NULL
to	NULL
an	NULL
antigen	NULL
is	NULL
due	NULL
,	NULL
at	NULL
least	NULL
partially	NULL
,	NULL
to	NULL
a	NULL
failure	NULL
to	NULL
induce	NULL
high-level	NULL
transcription	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
by	NULL
NFAT	NULL
.	NULL

Regulation	NULL
of	NULL
NFAT	NULL
could	NULL
be	NULL
therefore	NULL
a	NULL
critical	NULL
element	NULL
in	NULL
the	NULL
polarization	NULL
to	NULL
eThl	NULL
or	NULL
eTh2	NULL
.	NULL

The	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
was	NULL
originally	NULL
described	NULL
as	NULL
a	NULL
T-cell-specific	NULL
transcriptional	NULL
factor	NULL
which	NULL
was	NULL
expressed	NULL
in	NULL
activated	NULL
but	NULL
not	NULL
resting	NULL
T	NULL
cells	NULL
and	NULL
was	NULL
required	NULL
for	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
gene	NULL
transcription	NULL
(	NULL
13	NULL
,	NULL
58	NULL
,	NULL
59	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
now	NULL
know	NULL
that	NULL
NFAT	NULL
is	NULL
not	NULL
T	NULL
cell	NULL
specific	NULL
but	NULL
is	NULL
also	NULL
induced	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
lymphoid	NULL
cells	NULL
and	NULL
probably	NULL
in	NULL
nonlymphoid	NULL
tissues	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
NFAT	NULL
complex	NULL
consists	NULL
of	NULL
two	NULL
components	NULL
:	NULL
a	NULL
preexisting	NULL
cytoplasmic	NULL
component	NULL
and	NULL
a	NULL
nuclear	NULL
component	NULL
,	NULL
which	NULL
is	NULL
synthesized	NULL
de	NULL
novo	NULL
upon	NULL
activation	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
ubiquitous	NULL
nuclear	NULL
component	NULL
contains	NULL
members	NULL
of	NULL
the	NULL
Fos	NULL
and	NULL
Jun	NULL
protein	NULL
families	NULL
(	NULL
4	NULL
,	NULL
27	NULL
,	NULL
44	NULL
)	NULL
.	NULL

The	NULL
cytoplasmic	NULL
component	NULL
was	NULL
described	NULL
to	NULL
be	NULL
a	NULL
constitutive	NULL
T-cell-specific	NULL
protein	NULL
,	NULL
NFATp	NULL
or	NULL
NFATce	NULL
.	NULL

More	NULL
re-cently	NULL
,	NULL
the	NULL
identification	NULL
of	NULL
the	NULL
genes	NULL
that	NULL
encode	NULL
the	NULL
cytoplasmic	NULL
component	NULL
has	NULL
shown	NULL
that	NULL
NFAT	NULL
is	NULL
not	NULL
a	NULL
unique	NULL
protein	NULL
but	NULL
is	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
which	NULL
are	NULL
differentially	NULL
distributed	NULL
in	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
cells	NULL
.	NULL

NFATp	NULL
and	NULL
NFAT	NULL
are	NULL
highly	NULL
homologous	NULL
and	NULL
are	NULL
present	NULL
mainly	NULL
in	NULL
lymphoid	NULL
tissues	NULL
(	NULL
38	NULL
,	NULL
43	NULL
)	NULL
.	NULL

However	NULL
,	NULL
while	NULL
NFATe	NULL
is	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
only	NULL
upon	NULL
activation	NULL
,	NULL
NFATp	NULL
is	NULL
already	NULL
expressed	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
NFAT3	NULL
expression	NULL
is	NULL
present	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
spleen	NULL
and	NULL
thymus	NULL
,	NULL
but	NULL
it	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
nonlymphoid	NULL
tissues	NULL
(	NULL
placenta	NULL
,	NULL
kidney	NULL
,	NULL
lung	NULL
,	NULL
testis	NULL
,	NULL
and	NULL
ovary	NULL
)	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
NFATA4/NFAT	NULL
'	NULL
x	NULL
is	NULL
,	NULL
however	NULL
,	NULL
more	NULL
restricted	NULL
to	NULL
the	NULL
thymus	NULL
(	NULL
21	NULL
,	NULL
23	NULL
,	NULL
37	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
NFAT	NULL
requires	NULL
both	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
and	NULL
Ca**	NULL
signals	NULL
.	NULL

Activators	NULL
of	NULL
PKC	NULL
,	NULL
such	NULL
as	NULL
the	NULL
phorbol	NULL
ester	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
induce	NULL
the	NULL
synthesis	NULL
of	NULL
the	NULL
nuclear	NULL
component	NULL
(	NULL
4	NULL
,	NULL
16	NULL
,	NULL
27	NULL
,	NULL
43	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Section	NULL
of	NULL
Immunobiology	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
208011	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
06520-8011	NULL
.	NULL

Present	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Vermont	NULL
,	NULL
Burlington	NULL
,	NULL
VT	NULL
05405	NULL
.	NULL

1522	NULL
an	NULL
increase	NULL
in	NULL
intracellular	NULL
calcium	NULL
is	NULL
required	NULL
for	NULL
the	NULL
translocation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
component	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

This	NULL
translocation	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
Ca**-dependent	NULL
phosphatase	NULL
calcineurin	NULL
,	NULL
which	NULL
is	NULL
inhibited	NULL
by	NULL
the	NULL
immunosuppressive	NULL
drugs	NULL
cyclosporine	NULL
(	NULL
CsA	NULL
)	NULL
and	NULL
FK506	NULL
(	NULL
10	NULL
,	NULL
14	NULL
,	NULL
16	NULL
,	NULL
26	NULL
,	NULL
45	NULL
;	NULL
for	NULL
a	NULL
review	NULL
see	NULL
reference	NULL
56	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
NFAT	NULL
in	NULL
precursor	NULL
T	NULL
cells	NULL
directly	NULL
correlates	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
upon	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
-mediated	NULL
activation	NULL
.	NULL

However	NULL
,	NULL
NFAT	NULL
activity	NULL
can	NULL
also	NULL
be	NULL
detected	NULL
in	NULL
conditions	NULL
where	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
not	NULL
expressed	NULL
.	NULL

Thus	NULL
,	NULL
NFAT	NULL
DNA	NULL
binding	NULL
is	NULL
induced	NULL
in	NULL
B	NULL
cells	NULL
by	NULL
the	NULL
ligation	NULL
of	NULL
surface	NULL
immunoglobulins	NULL
or	NULL
CD40	NULL
receptors	NULL
,	NULL
which	NULL
trigger	NULL
Ca**-dependent	NULL
and	NULL
CsA-sensitive	NULL
pathways	NULL
(	NULL
8	NULL
,	NULL
66	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
lipopolysaccharide	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
stimulation	NULL
of	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
by	NULL
CD16	NULL
ligands	NULL
induces	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
a	NULL
CsA-sensitive	NULL
manner	NULL
(	NULL
2	NULL
)	NULL
.	NULL

This	NULL
wide	NULL
distribution	NULL
of	NULL
NFAT	NULL
indicates	NULL
that	NULL
NFAT	NULL
has	NULL
additional	NULL
targets	NULL
beyond	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
specific	NULL
NFAT	NULL
-binding	NULL
sites	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
several	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
IL-3	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
,	NULL
and	NULL
granulo-cyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
where	NULL
it	NULL
may	NULL
cooperate	NULL
with	NULL
other	NULL
transcriptional	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
AP-1	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
NFAT	NULL
may	NULL
therefore	NULL
correlate	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
specific	NULL
cytokines	NULL
,	NULL
independently	NULL
of	NULL
the	NULL
cell	NULL
type	NULL
.	NULL

Recognition	NULL
of	NULL
specific	NULL
major	NULL
histocompatibility	NULL
complex-peptide	NULL
complexes	NULL
on	NULL
antigen-presenting	NULL
cells	NULL
(	NULL
APC	NULL
)	NULL
via	NULL
the	NULL
TCR	NULL
complex	NULL
provides	NULL
the	NULL
first	NULL
signal	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
naive	NULL
(	NULL
precursor	NULL
)	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
second	NULL
,	NULL
costimulatory	NULL
signal	NULL
is	NULL
provided	NULL
by	NULL
accessory	NULL
molecules	NULL
expressed	NULL
on	NULL
APC	NULL
(	NULL
41	NULL
)	NULL
,	NULL
of	NULL
which	NULL
the	NULL
B7	NULL
family	NULL
of	NULL
proteins	NULL
is	NULL
the	NULL
most	NULL
widely	NULL
studied	NULL
.	NULL

The	NULL
B7	NULL
proteins	NULL
are	NULL
the	NULL
ligands	NULL
for	NULL
CD28	NULL
or	NULL
CTLA-4	NULL
which	NULL
are	NULL
expressed	NULL
on	NULL
T	NULL
cells	NULL
(	NULL
3	NULL
,	NULL
17	NULL
,	NULL
18	NULL
,	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
these	NULL
two	NULL
signals	NULL
induces	NULL
IL-2	NULL
synthesis	NULL
and	NULL
secre-tion	NULL
,	NULL
IL-2	NULL
receptor	NULL
expression	NULL
,	NULL
clonal	NULL
expansion	NULL
,	NULL
and	NULL
differentiation	NULL
of	NULL
precursor	NULL
T	NULL
helper	NULL
(	NULL
pTh	NULL
)	NULL
cells	NULL
into	NULL
effector	NULL
T	NULL
helper	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
(	NULL
eTh	NULL
)	NULL
cells	NULL
.	NULL

Two	NULL
subsets	NULL
of	NULL
eTh	NULL
cells	NULL
have	NULL
been	NULL
defined	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
their	NULL
distinct	NULL
cytokine	NULL
secretion	NULL
patterns	NULL
and	NULL
their	NULL
immunomodulatory	NULL
effects	NULL
(	NULL
40	NULL
,	NULL
46	NULL
)	NULL
.	NULL

eTh1	NULL
cells	NULL
produce	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
such	NULL
as	NULL
TNF-	NULL
and	NULL
gamma	NULL
interferon	NULL
(	NULL
IFN-y	NULL
)	NULL
,	NULL
and	NULL
enhance	NULL
cellular	NULL
immunity	NULL
mediated	NULL
by	NULL
macrophages	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
eTh2	NULL
cells	NULL
produce	NULL
a	NULL
different	NULL
group	NULL
of	NULL
cytokines	NULL
(	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
IL-6	NULL
,	NULL
IL-10	NULL
,	NULL
and	NULL
IL-13	NULL
)	NULL
and	NULL
help	NULL
B	NULL
cells	NULL
secrete	NULL
antibodies	NULL
.	NULL

The	NULL
differentiation	NULL
of	NULL
precursor	NULL
T	NULL
cells	NULL
into	NULL
eThl1	NULL
or	NULL
eTh2	NULL
cells	NULL
has	NULL
important	NULL
biologic	NULL
implications	NULL
in	NULL
terms	NULL
of	NULL
susceptibility	NULL
or	NULL
resistance	NULL
to	NULL
a	NULL
particular	NULL
disease	NULL
.	NULL

Different	NULL
factors	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
influence	NULL
differentiation	NULL
to	NULL
the	NULL
eTh1	NULL
or	NULL
eTh2	NULL
phenotype	NULL
,	NULL
such	NULL
as	NULL
the	NULL
antigen	NULL
dose	NULL
(	NULL
5	NULL
,	NULL
11	NULL
,	NULL
48	NULL
)	NULL
or	NULL
the	NULL
source	NULL
of	NULL
costimulation	NULL
(	NULL
31	NULL
,	NULL
34	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
most	NULL
effective	NULL
inducer	NULL
of	NULL
such	NULL
differentiation	NULL
is	NULL
the	NULL
cytokine	NULL
envi-ronment	NULL
.	NULL

Thus	NULL
,	NULL
IL-4	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
antigenic	NULL
and	NULL
costimulatory	NULL
signals	NULL
causes	NULL
pTh	NULL
cells	NULL
to	NULL
differentiate	NULL
into	NULL
eTh2	NULL
cells	NULL
(	NULL
33	NULL
,	NULL
61	NULL
)	NULL
,	NULL
while	NULL
IL-12	NULL
drives	NULL
pTh	NULL
cells	NULL
to	NULL
differentiate	NULL
into	NULL
eTh1	NULL
cells	NULL
(	NULL
25	NULL
,	NULL
57	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
distinction	NULL
between	NULL
eTh1l	NULL
and	NULL
eTh2	NULL
cells	NULL
is	NULL
unknown	NULL
.	NULL

Nevertheless	NULL
,	NULL
transcriptional	NULL
differences	NULL
may	NULL
account	NULL
for	NULL
the	NULL
specific	NULL
effector	NULL
functions	NULL
(	NULL
expres-sion	NULL
of	NULL
specific	NULL
cytokines	NULL
)	NULL
acquired	NULL
by	NULL
each	NULL
of	NULL
the	NULL
eTh	NULL
subsets	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
specific	NULL
transcriptional	NULL
factors	NULL
activated	NULL
in	NULL
these	NULL
cell	NULL
types	NULL
is	NULL
therefore	NULL
required	NULL
to	NULL
achieve	NULL
an	NULL
understanding	NULL
of	NULL
the	NULL
properties	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

Because	NULL
NFAT	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
certain	NULL
cytokines	NULL
,	NULL
it	NULL
is	NULL
a	NULL
likely	NULL
candidate	NULL
to	NULL
be	NULL
differentially	NULL
expressed	NULL
in	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

This	NULL
question	NULL
has	NULL
been	NULL
addressed	NULL
previously	NULL
by	NULL
analyzing	NULL
NFAT	NULL
activity	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
clones	NULL
(	NULL
53	NULL
,	NULL
54	NULL
)	NULL
,	NULL
and	NULL
in	NULL
those	NULL
studies	NULL
no	NULL
differences	NULL
were	NULL
found	NULL
between	NULL
both	NULL
kind	NULL
of	NULL
clones	NULL
.	NULL

However	NULL
,	NULL
not	NULL
much	NULL
is	NULL
known	NULL
about	NULL
the	NULL
regulation	NULL
of	NULL
NFAT	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
pTh	NULL
cells	NULL
into	NULL
eTh1	NULL
or	NULL
eTh2	NULL
cells	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
the	NULL
regulation	NULL
of	NULL
NFAT	NULL
activity	NULL
during	NULL
the	NULL
activation	NULL
of	NULL
mouse	NULL
pTh	NULL
cells	NULL
,	NULL
the	NULL
differentiation	NULL
of	NULL
naive	NULL
CD4	NULL
*	NULL
cells	NULL
into	NULL
eTh1	NULL
or	NULL
eTh2	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
these	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
one	NULL
particular	NULL
transcription	NULL
factor	NULL
to	NULL
bind	NULL
DNA	NULL
does	NULL
not	NULL
always	NULL
correlate	NULL
with	NULL
the	NULL
ability	NULL
to	NULL
mediate	NULL
transcription	NULL
.	NULL

Thus	NULL
,	NULL
several	NULL
transcriptional	NULL
factors	NULL
(	NULL
cyclic	NULL
AMP	NULL
-responsive	NULL
element	NULL
binding	NULL
protein	NULL
[	NULL
CREB	NULL
]	NULL
,	NULL
STAT-1	NULL
and	NULL
-3	NULL
,	NULL
and	NULL
AP-1	NULL
,	NULL
etc	NULL
.	NULL
)	NULL

require	NULL
an	NULL
additional	NULL
postranslational	NULL
modification	NULL
of	NULL
the	NULL
DNA-bound	NULL
complex	NULL
to	NULL
mediate	NULL
transcription	NULL
(	NULL
20	NULL
,	NULL
51	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
used	NULL
NFAT-luciferase	NULL
(	NULL
NFAT-Luc	NULL
)	NULL
reporter	NULL
transgenic	NULL
mice	NULL
,	NULL
which	NULL
we	NULL
have	NULL
previously	NULL
described	NULL
(	NULL
52	NULL
)	NULL
,	NULL
to	NULL
examine	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
during	NULL
T-cell	NULL
differentiation	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
is	NULL
regulated	NULL
similarly	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
pTh	NULL
cells	NULL
into	NULL
eTh1	NULL
cells	NULL
and	NULL
into	NULL
eTh2	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
is	NULL
rapidly	NULL
induced	NULL
at	NULL
high	NULL
levels	NULL
upon	NULL
stimulation	NULL
of	NULL
eTh2	NULL
cells	NULL
,	NULL
while	NULL
only	NULL
low	NULL
levels	NULL
are	NULL
detected	NULL
upon	NULL
stimulation	NULL
of	NULL
eTh1	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
only	NULL
small	NULL
differences	NULL
in	NULL
NFAT	NULL
DNA	NULL
binding	NULL
were	NULL
observed	NULL
,	NULL
and	NULL
NFAT	NULL
complexes	NULL
in	NULL
both	NULL
eTh1	NULL
and	NULL
eTh2	NULL
contain	NULL
NFAT	NULL
p	NULL
and	NULL
NFATe	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Mice	NULL
.	NULL

The	NULL
NFAT-Luc	NULL
reporter	NULL
transgenic	NULL
mice	NULL
have	NULL
been	NULL
generated	NULL
by	NULL
mi-croinjection	NULL
of	NULL
the	NULL
2.8-kb	NULL
BamHI	NULL
DNA	NULL
fragment	NULL
into	NULL
fertilized	NULL
(	NULL
C57BL/6	NULL
x	NULL
SJIL	NULL
)	NULL
F	NULL
,	NULL
eggs	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
NFAT-Luc	NULL
transgene	NULL
contains	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
driven	NULL
by	NULL
a	NULL
200-bp	NULL
fragment	NULL
of	NULL
the	NULL
IL-2	NULL
minimal	NULL
promoter	NULL
(	NULL
-326	NULL
to	NULL
-294	NULL
and	NULL
-72	NULL
to	NULL
+47	NULL
)	NULL
with	NULL
three	NULL
NFAT-binding	NULL
sites	NULL
inserted	NULL
in	NULL
an	NULL
Xhol	NULL
site	NULL
between	NULL
these	NULL
fragments	NULL
(	NULL
13	NULL
,	NULL
67	NULL
)	NULL
.	NULL

Three	NULL
expressing	NULL
positive	NULL
founder	NULL
lines	NULL
were	NULL
established	NULL
and	NULL
backcrossed	NULL
onto	NULL
B10.BR/SGSNJ	NULL
mice	NULL
(	NULL
Jackson	NULL
Laboratories	NULL
,	NULL
Bar	NULL
Harbor	NULL
,	NULL
Maine	NULL
)	NULL
to	NULL
obtain	NULL
progeny	NULL
for	NULL
these	NULL
studies	NULL
.	NULL

All	NULL
three	NULL
lines	NULL
display	NULL
the	NULL
same	NULL
pattern	NULL
but	NULL
different	NULL
levels	NULL
of	NULL
luciferase	NULL
expression	NULL
.	NULL

Most	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
transgenic	NULL
mice	NULL
from	NULL
line	NULL
83	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
the	NULL
indicated	NULL
experiments	NULL
.	NULL

The	NULL
cytochrome	NULL
c	NULL
(	NULL
Cyt	NULL
c	NULL
)	NULL
TCR	NULL
transgenic	NULL
mice	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
S.	NULL
M.	NULL
Hedrick	NULL
and	NULL
J.	NULL
Kaye	NULL
(	NULL
30	NULL
)	NULL
.	NULL

NFAT	NULL
TRANSCRIPTIONAL	NULL
ACTIVITY	NULL
IN	NULL
CD4+*	NULL
Th2	NULL
CELLS	NULL
|	NULL
1523	NULL
Cell	NULL
preparations	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
purified	NULL
from	NULL
lymph	NULL
nodes	NULL
from	NULL
NFAT-Luc	NULL
transgenic	NULL
mice	NULL
by	NULL
negative	NULL
selection	NULL
(	NULL
51	NULL
)	NULL
,	NULL
by	NULL
using	NULL
anti-major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
I-E/I-A	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MAb	NULL
)	NULL
(	NULL
m5/115	NULL
)	NULL
.	NULL

B	NULL
cells	NULL
were	NULL
purified	NULL
from	NULL
spleen	NULL
from	NULL
NFAT-Luc	NULL
transgenic	NULL
mice	NULL
,	NULL
by	NULL
negative	NULL
selection	NULL
,	NULL
by	NULL
incubation	NULL
with	NULL
anti-CD4	NULL
(	NULL
GK1.5	NULL
)	NULL
,	NULL
anti-CD8	NULL
(	NULL
TTB	NULL
105	NULL
)	NULL
,	NULL
and	NULL
anti-NK	NULL
(	NULL
NK1.1	NULL
;	NULL
Pharmingen	NULL
)	NULL
prior	NULL
the	NULL
treatment	NULL
with	NULL
rabbit	NULL
complement	NULL
for	NULL
45	NULL
min	NULL
at	NULL
37Â°C	NULL
.	NULL

CD4	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
spleen	NULL
and	NULL
lymph	NULL
nodes	NULL
from	NULL
double	NULL
transgenic	NULL
(	NULL
Cyt	NULL
c	NULL
TCR	NULL
x	NULL
NFAT-Luc	NULL
)	NULL
mice	NULL
by	NULL
negative	NULL
selection	NULL
(	NULL
29	NULL
,	NULL
51	NULL
)	NULL
and	NULL
cultured	NULL
(	NULL
10Â°	NULL
cells/ml	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
APC	NULL
(	NULL
5	NULL
X	NULL
10Â°	NULL
cell/ml	NULL
)	NULL
,	NULL
with	NULL
concanavalin	NULL
A	NULL
(	NULL
ConA	NULL
)	NULL
(	NULL
2.5	NULL
ug/ml	NULL
)	NULL
(	NULL
Boehringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
or	NULL
Cyt	NULL
c	NULL
peptide	NULL
(	NULL
5	NULL
g/m	NULL
!	NULL
)	NULL

plus	NULL
IL-4	NULL
(	NULL
10Â°	NULL
U/ml	NULL
)	NULL
or	NULL
IL-12	NULL
(	NULL
3.5	NULL
ng/ml	NULL
)	NULL
.	NULL

After	NULL
4	NULL
days	NULL
,	NULL
cells	NULL
were	NULL
exhaustively	NULL
washed	NULL
and	NULL
restimulated	NULL
(	NULL
eTh	NULL
cells	NULL
)	NULL
.	NULL

APC	NULL
were	NULL
generated	NULL
from	NULL
B10.BR	NULL
splenocytes	NULL
by	NULL
treatment	NULL
with	NULL
mitomycin	NULL
(	NULL
50	NULL
g/m	NULL
!	NULL
)	NULL

(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

for	NULL
45	NULL
min	NULL
.	NULL

1-Ethyl-3-	NULL
(	NULL
3-dimethylaminopro-pyl	NULL
)	NULL
-carbodimide	NULL
(	NULL
ECDI	NULL
)	NULL
-fixed	NULL
APC	NULL
were	NULL
obtained	NULL
by	NULL
fixation	NULL
of	NULL
B10.BR	NULL
splenocytes	NULL
with	NULL
ECDI	NULL
(	NULL
75	NULL
mM	NULL
)	NULL
(	NULL
Calbiochem	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4Â°C	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
.	NULL

Luciferase	NULL
activity	NULL
in	NULL
the	NULL
cell	NULL
extracts	NULL
was	NULL
measured	NULL
(	NULL
51	NULL
)	NULL
with	NULL
a	NULL
luciferase	NULL
assay	NULL
kit	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
luciferase	NULL
activity	NULL
compared	NULL
with	NULL
that	NULL
found	NULL
in	NULL
extracts	NULL
from	NULL
unstimulated	NULL
cells	NULL
is	NULL
pre-sented	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

``	NULL
Mini	NULL
``	NULL
nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
from	NULL
2	NULL
X	NULL
10Â°	NULL
to	NULL
3	NULL
X	NULL
10Â°	NULL
cells	NULL
by	NULL
a	NULL
previously	NULL
described	NULL
procedure	NULL
(	NULL
55	NULL
,	NULL
65	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
done	NULL
using	NULL
1.5	NULL
pg	NULL
of	NULL
nuclear	NULL
protein	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
X	NULL
10*	NULL
cpm	NULL
of	NULL
the	NULL
specific	NULL
*Â°P-end-labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
for	NULL
25	NULL
min	NULL
at	NULL
4Â°C	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
55	NULL
,	NULL
65	NULL
)	NULL
.	NULL

The	NULL
oligonucleotides	NULL
that	NULL
have	NULL
been	NULL
used	NULL
in	NULL
this	NULL
study	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
IL2-NFAT	NULL
,	NULL
5'GCCCAAAGAGGAAAATITGTITCATACAG3	NULL
'	NULL
(	NULL
27	NULL
)	NULL
;	NULL
II4-NFAT	NULL
(	NULL
-60	NULL
to	NULL
-83	NULL
)	NULL
5GTAATAAAATTITTCCAATGTAAA3	NULL
'	NULL
(	NULL
53	NULL
)	NULL
;	NULL
long	NULL
IIL	NULL
A-NFAT	NULL
(	NULL
-60	NULL
to	NULL
-91	NULL
)	NULL
(	NULL
54	NULL
)	NULL
;	NULL
AP-1	NULL
(	NULL
1	NULL
,	NULL
32	NULL
)	NULL
;	NULL
and	NULL
CRE	NULL
,	NULL
5'GATCT	NULL
CTCTGACGTCAGCCAAGGAGGAGGCC3	NULL
'	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Cytokine	NULL
production	NULL
.	NULL

IL-4	NULL
and	NULL
IFN-y	NULL
secretion	NULL
was	NULL
analyzed	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
using	NULL
purified	NULL
(	NULL
3	NULL
pg/ml	NULL
)	NULL
and	NULL
biotinylated	NULL
(	NULL
1	NULL
pg/ml	NULL
!	NULL
)	NULL

anti-IL-4	NULL
or	NULL
anti-IFN-y	NULL
MAbs	NULL
(	NULL
Pharmingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
horseradish	NULL
peroxi-dase-conjugated	NULL
avidin	NULL
D	NULL
(	NULL
2.5	NULL
g/m	NULL
!	NULL
)	NULL

(	NULL
Vector	NULL
Laboratories	NULL
,	NULL
Burlingame	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
and	NULL
the	NULL
TMB	NULL
microwell	NULL
peroxidase	NULL
substrate	NULL
and	NULL
stop	NULL
solution	NULL
(	NULL
Kirkegaard	NULL
&	NULL
Perry	NULL
Laboratories	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

.	NULL

Recombinant	NULL
IL-4	NULL
(	NULL
DNAX	NULL
,	NULL
Los	NULL
Ange-les	NULL
,	NULL
Calif.	NULL
)	NULL
and	NULL
IFN-y	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

were	NULL
used	NULL
as	NULL
standards	NULL
.	NULL

IL-2	NULL
production	NULL
was	NULL
analyzed	NULL
by	NULL
using	NULL
the	NULL
CTL.L	NULL
line	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Reagents	NULL
and	NULL
antisera	NULL
.	NULL

In	NULL
the	NULL
T-cell	NULL
activation	NULL
and	NULL
differentiation	NULL
studies	NULL
,	NULL
we	NULL
have	NULL
used	NULL
ConA	NULL
(	NULL
Boehringer	NULL
)	NULL
,	NULL
anti-CD3	NULL
MAb	NULL
(	NULL
145-2C11	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
ionomycin	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
synthetic	NULL
moth	NULL
Cyt	NULL
c	NULL
peptide	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
K.	NULL
Bottomly	NULL
,	NULL
Yale	NULL
University	NULL
)	NULL
,	NULL
IL-4	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
DNAX	NULL
)	NULL
,	NULL
IL-12	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Genetics	NULL
Institute	NULL
)	NULL
,	NULL
and	NULL
CTLA4-Ig	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
P.	NULL
Linsley	NULL
)	NULL
.	NULL

Anti-NFATp	NULL
antiserum	NULL
(	NULL
27	NULL
)	NULL
was	NULL
supplied	NULL
by	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Anti-NFATc	NULL
and	NULL
anti-NFATp	NULL
'	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
G.	NULL
Crabtree	NULL
.	NULL

RESULTS	NULL
Generation	NULL
of	NULL
NFAT	NULL
reporter	NULL
transgenic	NULL
mice	NULL
.	NULL

To	NULL
study	NULL
the	NULL
regulation	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
during	NULL
activation	NULL
and	NULL
differentiation	NULL
of	NULL
mouse	NULL
primary	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
generated	NULL
luciferase	NULL
reporter	NULL
transgenic	NULL
mice	NULL
for	NULL
NFAT	NULL
(	NULL
NFAT-Luc	NULL
)	NULL
.	NULL

We	NULL
microinjected	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
driven	NULL
by	NULL
three	NULL
NFAT	NULL
binding	NULL
sites	NULL
(	NULL
13	NULL
,	NULL
67	NULL
)	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
IL-2	NULL
minimal	NULL
promoter	NULL
.	NULL

This	NULL
construct	NULL
has	NULL
been	NULL
previously	NULL
used	NULL
to	NULL
generate	NULL
reporter	NULL
transgenic	NULL
mice	NULL
by	NULL
using	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
large	NULL
T	NULL
antigen	NULL
as	NULL
a	NULL
reporter	NULL
gene	NULL
(	NULL
67	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
activity	NULL
is	NULL
the	NULL
readout	NULL
system	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
endogenous	NULL
NFAT	NULL
to	NULL
mediate	NULL
specific	NULL
transcription	NULL
.	NULL

Three	NULL
different	NULL
expressing	NULL
founders	NULL
containing	NULL
the	NULL
luciferase	NULL
gene	NULL
were	NULL
identified	NULL
,	NULL
and	NULL
they	NULL
were	NULL
backcrossed	NULL
to	NULL
produce	NULL
stable	NULL
lines	NULL
of	NULL
transgenic	NULL
mice	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
luciferase	NULL
expression	NULL
in	NULL
these	NULL
transgenic	NULL
mice	NULL
,	NULL
we	NULL
stimulated	NULL
total	NULL
spleen	NULL
cells	NULL
for	NULL
different	NULL
times	NULL
with	NULL
PMA	NULL
(	NULL
a	NULL
PKC	NULL
activator	NULL
)	NULL
plus	NULL
ionomycin	NULL
(	NULL
calcium	NULL
ionophore	NULL
)	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
analyzed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Although	NULL
no	NULL
luciferase	NULL
expression	NULL
was	NULL
detected	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
significant	NULL
luciferase	NULL
activity	NULL
was	NULL
observed	NULL
in	NULL
cells	NULL
from	NULL
transgenic	NULL
mice	NULL
from	NULL
lines	NULL
83	NULL
,	NULL
91	NULL
,	NULL
and	NULL
110	NULL
upon	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

NFAT	NULL
transcriptional	NULL
activity	NULL
was	NULL
therefore	NULL
inducible	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
in	NULL
primary	NULL
spleen	NULL
cells	NULL
,	NULL
in	NULL
correlation	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
NFAT	NULL
DNA	NULL
binding	NULL
(	NULL
67	NULL
)	NULL
.	NULL

Analysis	NULL
by	NULL
reverse	NULL
transcriptase	NULL
PCR	NULL
has	NULL
shown	NULL
1524	NULL
RINCON	NULL
AND	NULL
FLAVELL	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
-	NULL
5000	NULL
7	NULL
_	NULL
800	NULL
{	NULL
O	NULL
24h	NULL
5	NULL
{	NULL
]	NULL
24h	NULL
HN	NULL
36h	NULL
E	NULL
H	NULL
ssn	NULL
48	NULL
h	NULL
e	NULL
48	NULL
h	NULL
4000	NULL
7	NULL
600	NULL
-	NULL
H	NULL
728	NULL
S	NULL
2	NULL
>	NULL
3000	NULL
7	NULL
B	NULL
6	NULL
400	NULL
<	NULL
a	NULL
2000	NULL
7	NULL
S	NULL
2	NULL
o	NULL
3	NULL
200	NULL
1000	NULL
@	NULL
2	NULL
@	NULL
@	NULL
Â£2	NULL
o	NULL
-	NULL
0	NULL
#	NULL
110	NULL
B	NULL
C	NULL
700	NULL
-	NULL
500	NULL
--	NULL
#	NULL
Â®	NULL
--	NULL
-	NULL
PMA	NULL
(	NULL
Â§	NULL
ng/m	NULL
!	NULL
)	NULL

~	NULL
T=	NULL
-R-	NULL
_	NULL
ion	NULL
(	NULL
250	NULL
ng/m	NULL
!	NULL
)	NULL

8	NULL
-	NULL
600	NULL
-	NULL
T	NULL
cells	NULL
B	NULL
--	NULL
o0	NULL
--	NULL
-	NULL
lon	NULL
(	NULL
500	NULL
ng/im	NULL
}	NULL
)	NULL
3	NULL
--	NULL
@	NULL
-	NULL
B	NULL
cells	NULL
B	NULL
400	NULL
-	NULL
--	NULL
D	NULL
--	NULL
_	NULL
P/	NULL
(	NULL
250	NULL
ng/ml	NULL
)	NULL
a	NULL
B	NULL
-B-	NULL
_	NULL
P/	NULL
{	NULL
500	NULL
ng/m	NULL
!	NULL
)	NULL

o	NULL
Â£	NULL
-	NULL
C	NULL
g	NULL
50	NULL
3	NULL
g	NULL
hal	NULL
&	NULL
300	NULL
{	NULL
â¬	NULL
400	NULL
{	NULL
s	NULL
>	NULL
3	NULL
=	NULL
o	NULL
0	NULL
<	NULL
4	NULL
<	NULL
4	NULL
&	NULL
o	NULL
a	NULL
800	NULL
Â§	NULL
200	NULL
4	NULL
S	NULL
Â£	NULL
Â£	NULL
E	NULL
o	NULL
3	NULL
200	NULL
{	NULL
@	NULL
$	NULL
2	NULL
2	NULL
&	NULL
100	NULL
{	NULL
Â®	NULL
100	NULL
-	NULL
&	NULL
CC	NULL
0	NULL
LEP	NULL
T	NULL
T	NULL
r	NULL
1	NULL
0	NULL
AF	NULL
T	NULL
T	NULL
Ler	NULL
T	NULL
&	NULL
i	NULL
20	NULL
30	NULL
40	NULL
50	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
70	NULL
80	NULL
Activation	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Activation	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Generation	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
NFAT	NULL
reporter	NULL
transgenic	NULL
mice	NULL
.	NULL

(	NULL
A	NULL
)	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
activated	NULL
splenocytes	NULL
.	NULL

Spleen	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10Â°	NULL
)	NULL
from	NULL
different	NULL
lines	NULL
of	NULL
reporter	NULL
transgenic	NULL
mice	NULL
(	NULL
83	NULL
,	NULL
91	NULL
,	NULL
and	NULL
110	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
ionomycin	NULL
(	NULL
250	NULL
ng/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

(	NULL
B	NULL
)	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

T	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10Â°	NULL
)	NULL
from	NULL
lymph	NULL
nodes	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10Â°	NULL
)	NULL
from	NULL
spleens	NULL
of	NULL
transgenic	NULL
mice	NULL
(	NULL
founder	NULL
line	NULL
83	NULL
)	NULL
were	NULL
purified	NULL
by	NULL
negative	NULL
selection	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
and	NULL
activated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
.	NULL

After	NULL
different	NULL
periods	NULL
of	NULL
time	NULL
,	NULL
luciferase	NULL
activity	NULL
was	NULL
analyzed	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Ca**	NULL
requirement	NULL
for	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
.	NULL

Spleen	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10Â°	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
,	NULL
ionomycin	NULL
(	NULL
Ion	NULL
)	NULL
(	NULL
250	NULL
or	NULL
500	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
ionomycin	NULL
(	NULL
250	NULL
or	NULL
500	NULL
ng/m	NULL
!	NULL
)	NULL

(	NULL
P/T	NULL
)	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
before	NULL
harvesting	NULL
for	NULL
luciferase	NULL
activity	NULL
analysis	NULL
.	NULL

that	NULL
the	NULL
luciferase	NULL
transcripts	NULL
initiate	NULL
around	NULL
the	NULL
predicted	NULL
5	NULL
'	NULL
end	NULL
for	NULL
these	NULL
promoters	NULL
and	NULL
that	NULL
there	NULL
is	NULL
no	NULL
significant	NULL
level	NULL
of	NULL
readthrough	NULL
from	NULL
any	NULL
other	NULL
endogenous	NULL
promoter	NULL
in	NULL
the	NULL
vicinity	NULL
of	NULL
the	NULL
integration	NULL
site	NULL
of	NULL
the	NULL
transgene	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

NFAT	NULL
was	NULL
originally	NULL
described	NULL
as	NULL
an	NULL
inducible	NULL
T-cell-specific	NULL
DNA-binding	NULL
protein	NULL
required	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
IL-2	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
13	NULL
,	NULL
58	NULL
,	NULL
59	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
demonstrated	NULL
that	NULL
NFAT	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activity	NULL
are	NULL
also	NULL
induced	NULL
in	NULL
thymocytes	NULL
after	NULL
stimulation	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
7	NULL
,	NULL
52	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NFAT	NULL
DNA	NULL
binding	NULL
is	NULL
also	NULL
induced	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
8	NULL
,	NULL
66	NULL
,	NULL
67	NULL
,	NULL
69	NULL
)	NULL
,	NULL
but	NULL
whether	NULL
this	NULL
NFAT	NULL
is	NULL
able	NULL
to	NULL
mediate	NULL
transcription	NULL
in	NULL
normal	NULL
B	NULL
cells	NULL
remains	NULL
controversial	NULL
.	NULL

We	NULL
examined	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
isolated	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
therefore	NULL
,	NULL
to	NULL
discriminate	NULL
which	NULL
population	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
activity	NULL
detected	NULL
in	NULL
activated	NULL
splenocytes	NULL
.	NULL

NFAT	NULL
transcriptional	NULL
activity	NULL
was	NULL
induced	NULL
in	NULL
both	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
for	NULL
different	NULL
periods	NULL
of	NULL
time	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
while	NULL
in	NULL
T	NULL
cells	NULL
NFAT	NULL
activity	NULL
gradually	NULL
increased	NULL
with	NULL
time	NULL
,	NULL
in	NULL
B	NULL
cells	NULL
it	NULL
was	NULL
induced	NULL
more	NULL
rapidly	NULL
and	NULL
decayed	NULL
after	NULL
36	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
same	NULL
dose	NULL
of	NULL
PMA	NULL
in	NULL
combination	NULL
with	NULL
a	NULL
higher	NULL
dose	NULL
of	NULL
ionomycin	NULL
(	NULL
500	NULL
ng/ml	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
further	NULL
increase	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
10	NULL
times	NULL
greater	NULL
than	NULL
the	NULL
activity	NULL
observed	NULL
with	NULL
the	NULL
lower	NULL
dose	NULL
of	NULL
iono-	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
mycin	NULL
)	NULL
but	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
NFAT	NULL
DNA	NULL
binding	NULL
requires	NULL
both	NULL
PKC	NULL
and	NULL
Ca**	NULL
signals	NULL
to	NULL
trigger	NULL
the	NULL
synthesis	NULL
of	NULL
the	NULL
nuclear	NULL
component	NULL
and	NULL
translocation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
component	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
respectively	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
correlation	NULL
with	NULL
these	NULL
obser-vations	NULL
,	NULL
neither	NULL
PMA	NULL
alone	NULL
nor	NULL
ionomycin	NULL
alone	NULL
was	NULL
sufficient	NULL
to	NULL
stimulate	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
,	NULL
but	NULL
it	NULL
was	NULL
induced	NULL
after	NULL
treatment	NULL
with	NULL
PMA	NULL
in	NULL
combination	NULL
of	NULL
ionomycin	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

These	NULL
data	NULL
support	NULL
the	NULL
idea	NULL
that	NULL
NFAT	NULL
mediates	NULL
transcription	NULL
not	NULL
only	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
also	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Costimulation	NULL
requirement	NULL
for	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
precursor	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
regulation	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
by	NULL
TCR-mediated	NULL
signals	NULL
,	NULL
we	NULL
stimulated	NULL
total	NULL
spleen	NULL
cells	NULL
with	NULL
anti-CD3	NULL
MAb	NULL
in	NULL
different	NULL
transgenic	NULL
mouse	NULL
lines	NULL
.	NULL

Anti-CD3	NULL
MAb	NULL
was	NULL
also	NULL
able	NULL
to	NULL
transiently	NULL
induce	NULL
high	NULL
levels	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
in	NULL
the	NULL
different	NULL
lines	NULL
of	NULL
transgenic	NULL
mice	NULL
correlated	NULL
with	NULL
the	NULL
level	NULL
obtained	NULL
after	NULL
PMA-plus-ionomycin	NULL
treatment	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
Ca**	NULL
and	NULL
PKC	NULL
signals	NULL
delivered	NULL
by	NULL
the	NULL
TCR	NULL
,	NULL
activation	NULL
of	NULL
naive	NULL
T	NULL
cells	NULL
requires	NULL
a	NULL
second	NULL
,	NULL
antigen-independent	NULL
costimulatory	NULL
signal	NULL
,	NULL
which	NULL
is	NULL
provided	NULL
by	NULL
the	NULL
APC	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
B7-1	NULL
and	NULL
B7-2	NULL
molecules	NULL
expressed	NULL
on	NULL
APC	NULL
with	NULL
their	NULL
receptors	NULL
(	NULL
CD28	NULL
or	NULL
CTLA-4	NULL
)	NULL
expressed	NULL
on	NULL
T	NULL
cells	NULL
is	NULL
the	NULL
best-characterized	NULL
source	NULL
of	NULL
costimulation	NULL
(	NULL
3	NULL
,	NULL
17	NULL
,	NULL
18	NULL
,	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
costimulatory	NULL
molecules	NULL
regulate	NULL
IL-2	NULL
gene	NULL
expression	NULL
is	NULL
not	NULL
completely	NULL
understood	NULL
yet	NULL
.	NULL

We	NULL
and	NULL
others	NULL
(	NULL
51	NULL
,	NULL
60	NULL
)	NULL
have	NULL
described	NULL
that	NULL
costimulation	NULL
is	NULL
required	NULL
to	NULL
induce	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
order	NULL
to	NULL
elucidate	NULL
the	NULL
role	NULL
of	NULL
costimulation	NULL
in	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
NFAT	NULL
,	NULL
we	NULL
examined	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
during	NULL
the	NULL
activation	NULL
of	NULL
precursor	NULL
(	NULL
naive	NULL
)	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
used	NULL
Â«	NULL
/B	NULL
TCR	NULL
transgenic	NULL
mice	NULL
(	NULL
Cyt	NULL
c	NULL
TCR	NULL
)	NULL
which	NULL
express	NULL
a	NULL
receptor	NULL
specific	NULL
for	NULL
a	NULL
peptide	NULL
from	NULL
pigeon	NULL
Cyt	NULL
c	NULL
in	NULL
association	NULL
with	NULL
I-E	NULL
``	NULL
major	NULL
histocompatibility	NULL
complex	NULL
II	NULL
(	NULL
30	NULL
)	NULL
.	NULL

These	NULL
mice	NULL
were	NULL
crossed	NULL
with	NULL
NFAT-Luc	NULL
reporter	NULL
transgenic	NULL
mice	NULL
.	NULL

CD4	NULL
*	NULL
pTh	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
mainly	NULL
a	NULL
naive	NULL
phenotype	NULL
(	NULL
approximately	NULL
95	NULL
%	NULL
CD4SR	NULL
``	NULL
s	NULL
``	NULL
CD44	NULL
``	NULL
)	NULL
,	NULL
from	NULL
double	NULL
transgenic	NULL
mice	NULL
(	NULL
Cyt	NULL
c	NULL
TCR	NULL
X	NULL
NFAT-Luc	NULL
)	NULL
were	NULL
purified	NULL
and	NULL
stimulated	NULL
with	NULL
soluble	NULL
anti-CD3	NULL
MAb	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
APC	NULL
,	NULL
anti-CD3	NULL
MAb	NULL
induced	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
pTh	NULL
cells	NULL
.	NULL

When	NULL
APC	NULL
have	NULL
been	NULL
previously	NULL
fixed	NULL
(	NULL
by	NULL
using	NULL
ECDI	NULL
,	NULL
they	NULL
are	NULL
able	NULL
to	NULL
efficiently	NULL
present	NULL
antigen	NULL
and	NULL
mediate	NULL
anti-CD3	NULL
MAb	NULL
cross-linking	NULL
but	NULL
can	NULL
not	NULL
provide	NULL
the	NULL
costimulatory	NULL
signal	NULL
(	NULL
28	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
fixed	NULL
APC	NULL
,	NULL
anti-CD3	NULL
MAb	NULL
failed	NULL
to	NULL
induce	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
soluble	NULL
CTLA4-Ig	NULL
(	NULL
which	NULL
blocks	NULL
the	NULL
CD28/CTLA4	NULL
pathway	NULL
by	NULL
binding	NULL
both	NULL
B7-1	NULL
and	NULL
B7-2	NULL
molecules	NULL
)	NULL
also	NULL
blocked	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
induced	NULL
by	NULL
anti-CD3	NULL
MAb	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
APC	NULL
.	NULL

Although	NULL
immobilized	NULL
anti-CD3	NULL
MAb	NULL
is	NULL
a	NULL
strong	NULL
stimulus	NULL
which	NULL
mimics	NULL
the	NULL
TCR	NULL
cross-linking	NULL
caused	NULL
by	NULL
the	NULL
APC	NULL
and	NULL
it	NULL
is	NULL
able	NULL
to	NULL
deliver	NULL
both	NULL
PKC	NULL
and	NULL
Ca**	NULL
signals	NULL
,	NULL
a	NULL
second	NULL
signal	NULL
provided	NULL
by	NULL
APC	NULL
was	NULL
also	NULL
required	NULL
for	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
to	NULL
be	NULL
induced	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Together	NULL
these	NULL
data	NULL
provide	NULL
evidence	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
by	NULL
NFAT	NULL
in	NULL
pTh	NULL
cells	NULL
is	NULL
dependent	NULL
on	NULL
costimulation	NULL
.	NULL

Regulation	NULL
of	NULL
NFAT	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
precursor	NULL
CD4*	NULL
T	NULL
cells	NULL
into	NULL
effector	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
regulation	NULL
of	NULL
NFAT	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
CD4	NULL
*	NULL
pTh	NULL
cells	NULL
into	NULL
CD4*	NULL
eTh	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
an	NULL
established	NULL
procedure	NULL
(	NULL
29	NULL
)	NULL
in	NULL
which	NULL
precursor	NULL
CD4*	NULL
T	NULL
cells	NULL
purified	NULL
from	NULL
double	NULL
transgenic	NULL
mice	NULL
(	NULL
Cyt	NULL
c	NULL
TCR	NULL
X	NULL
NFAT	NULL
-luc	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
the	NULL
polyclonal	NULL
stimulator	NULL
ConA	NULL
or	NULL
specific	NULL
Cyt	NULL
c	NULL
peptide	NULL
together	NULL
with	NULL
exogenous	NULL
APC	NULL
for	NULL
4	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
IL-4	NULL
to	NULL
the	NULL
culture	NULL
drives	NULL
the	NULL
differentiation	NULL
of	NULL
pTh	NULL
cells	NULL
into	NULL
cells	NULL
with	NULL
the	NULL
eTh2	NULL
phenotype	NULL
(	NULL
33	NULL
,	NULL
61	NULL
)	NULL
,	NULL
while	NULL
the	NULL
presence	NULL
of	NULL
NFAT	NULL
TRANSCRIPTIONAL	NULL
ACTIVITY	NULL
IN	NULL
CD4+*	NULL
Th2	NULL
CELLS	NULL
|	NULL
1525	NULL
IL-12	NULL
directs	NULL
the	NULL
differentiation	NULL
of	NULL
pTh	NULL
cells	NULL
to	NULL
eTh1	NULL
cells	NULL
(	NULL
25	NULL
,	NULL
57	NULL
)	NULL
.	NULL

We	NULL
first	NULL
examined	NULL
the	NULL
regulation	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
pTh	NULL
cells	NULL
to	NULL
eTh	NULL
cells	NULL
.	NULL

NFAT	NULL
transcriptional	NULL
activity	NULL
was	NULL
induced	NULL
similarly	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
pTh	NULL
cells	NULL
into	NULL
either	NULL
eTh2	NULL
cells	NULL
(	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
)	NULL
or	NULL
eTh1	NULL
cells	NULL
(	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
)	NULL
by	NULL
ConA	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
or	NULL
peptide	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
stimulation	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
induced	NULL
by	NULL
peptide	NULL
stimulation	NULL
(	NULL
peak	NULL
at	NULL
day	NULL
2	NULL
)	NULL
seemed	NULL
,	NULL
however	NULL
,	NULL
to	NULL
be	NULL
faster	NULL
than	NULL
the	NULL
kinetics	NULL
observed	NULL
with	NULL
ConA	NULL
stimulation	NULL
(	NULL
peak	NULL
at	NULL
day	NULL
3	NULL
)	NULL
.	NULL

With	NULL
both	NULL
stimuli	NULL
,	NULL
however	NULL
,	NULL
the	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
decayed	NULL
to	NULL
low	NULL
levels	NULL
by	NULL
day	NULL
4	NULL
,	NULL
at	NULL
which	NULL
time	NULL
eTh	NULL
cells	NULL
have	NULL
developed	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
no	NULL
significant	NULL
differences	NULL
were	NULL
observed	NULL
between	NULL
the	NULL
regulation	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
during	NULL
the	NULL
course	NULL
of	NULL
differentiation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-12	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
NFAT	NULL
DNA	NULL
binding	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
by	NULL
EMSA	NULL
using	NULL
extract	NULL
from	NULL
CD4*	NULL
pTh	NULL
cells	NULL
stimulated	NULL
with	NULL
ConA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-12	NULL
for	NULL
different	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

DNA	NULL
binding	NULL
was	NULL
rapidly	NULL
induced	NULL
after	NULL
activation	NULL
and	NULL
decreased	NULL
with	NULL
time	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

Little	NULL
difference	NULL
in	NULL
NFAT	NULL
DNA	NULL
binding	NULL
was	NULL
detected	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
pTh	NULL
cells	NULL
to	NULL
eTh2	NULL
or	NULL
eTh1	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
IL-4	NULL
or	NULL
IL-12	NULL
,	NULL
respectively	NULL
.	NULL

After	NULL
4	NULL
days	NULL
,	NULL
low	NULL
but	NULL
significant	NULL
levels	NULL
of	NULL
NFAT	NULL
complexes	NULL
remained	NULL
present	NULL
in	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
indicated	NULL
that	NULL
both	NULL
NFAT	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activities	NULL
were	NULL
regulated	NULL
similarly	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
pTh	NULL
cells	NULL
into	NULL
eTh1	NULL
or	NULL
eTh2	NULL
cells	NULL
.	NULL

NFAT	NULL
transcriptional	NULL
activity	NULL
is	NULL
induced	NULL
in	NULL
activated	NULL
eTh2	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
eTh1	NULL
cells	NULL
.	NULL

The	NULL
ability	NULL
to	NULL
express	NULL
and	NULL
secrete	NULL
specific	NULL
cytokines	NULL
upon	NULL
activation	NULL
is	NULL
the	NULL
principal	NULL
characteristic	NULL
that	NULL
defines	NULL
the	NULL
two	NULL
subsets	NULL
of	NULL
effector	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

While	NULL
activated	NULL
eTh2	NULL
cells	NULL
produce	NULL
mainly	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
IL-6	NULL
,	NULL
IL-10	NULL
,	NULL
and	NULL
IL-13	NULL
,	NULL
stimulation	NULL
of	NULL
eTh1	NULL
cells	NULL
results	NULL
in	NULL
the	NULL
secretion	NULL
of	NULL
IFN-y	NULL
,	NULL
TNF-B	NULL
,	NULL
and	NULL
IL-2	NULL
,	NULL
suggesting	NULL
the	NULL
differential	NULL
distribution	NULL
of	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
those	NULL
cytokines	NULL
(	NULL
40	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Since	NULL
NFAT	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
several	NULL
cytokines	NULL
(	NULL
49	NULL
)	NULL
,	NULL
such	NULL
as	NULL
IL-4	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
regulation	NULL
of	NULL
this	NULL
transcriptional	NULL
factor	NULL
during	NULL
the	NULL
activation	NULL
of	NULL
eThl	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

We	NULL
first	NULL
confirmed	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
system	NULL
whereby	NULL
pTh	NULL
cells	NULL
differentiated	NULL
to	NULL
either	NULL
the	NULL
eTh1	NULL
or	NULL
eTh2	NULL
phenotype	NULL
,	NULL
by	NULL
analyzing	NULL
the	NULL
effector	NULL
molecules	NULL
that	NULL
were	NULL
expressed	NULL
after	NULL
stimulation	NULL
.	NULL

IL-4	NULL
production	NULL
was	NULL
detected	NULL
only	NULL
in	NULL
eTh2	NULL
and	NULL
not	NULL
eTh1	NULL
cells	NULL
upon	NULL
stimulation	NULL
with	NULL
either	NULL
ConA	NULL
or	NULL
Cyt	NULL
c	NULL
peptide	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IFN-y	NULL
was	NULL
secreted	NULL
by	NULL
stimulated	NULL
eTh1	NULL
but	NULL
not	NULL
eTh2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
regulation	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
during	NULL
the	NULL
activation	NULL
of	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

After	NULL
4	NULL
days	NULL
of	NULL
differentiation	NULL
with	NULL
ConA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-12	NULL
,	NULL
effector	NULL
cells	NULL
were	NULL
exhaustively	NULL
washed	NULL
and	NULL
activated	NULL
with	NULL
different	NULL
stimuli	NULL
.	NULL

Interestingly	NULL
,	NULL
extremely	NULL
high	NULL
levels	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
were	NULL
induced	NULL
in	NULL
eTh2	NULL
cells	NULL
upon	NULL
stimulation	NULL
with	NULL
ConA	NULL
or	NULL
immobilized	NULL
anti-CD3	NULL
MAb	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

NFAT	NULL
transcriptional	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
eTh1	NULL
cells	NULL
upon	NULL
stimulation	NULL
with	NULL
immobilized	NULL
anti-CD3	NULL
MAb	NULL
,	NULL
although	NULL
it	NULL
was	NULL
10-	NULL
to	NULL
15-fold	NULL
less	NULL
than	NULL
the	NULL
NFAT	NULL
activity	NULL
of	NULL
eTh2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

This	NULL
residual	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
observed	NULL
in	NULL
eTh1	NULL
cells	NULL
correlated	NULL
with	NULL
the	NULL
low	NULL
but	NULL
detectable	NULL
production	NULL
of	NULL
IL-2	NULL
and	NULL
IL-4	NULL
by	NULL
these	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
possibly	NULL
due	NULL
in	NULL
part	NULL
to	NULL
the	NULL
strong	NULL
stimulus	NULL
triggered	NULL
by	NULL
anti-CD3	NULL
MAb	NULL
.	NULL

NFAT	NULL
transcriptional	NULL
activity	NULL
was	NULL
not	NULL
induced	NULL
by	NULL
PMA	NULL
alone	NULL
or	NULL
ionomycin	NULL
alone	NULL
,	NULL
indicating	NULL
that	NULL
,	NULL
in	NULL
effector	NULL
cells	NULL
,	NULL
NFAT	NULL
also	NULL
required	NULL
both	NULL
PKC	NULL
and	NULL
Ca**	NULL
signals	NULL
.	NULL

AP-1	NULL
transcriptional	NULL
activity	NULL
,	NULL
however	NULL
,	NULL
was	NULL
induced	NULL
by	NULL
PMA	NULL
alone	NULL
in	NULL
effector	NULL
T	NULL
cells	NULL
1526	NULL
RINCON	NULL
AND	NULL
FLAVELL	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
4000	NULL
7	NULL
--	NULL
LQ	NULL
--	NULL
#	NULL
83	NULL
C	NULL
0	NULL
4	NULL
0	NULL
-	NULL
]	NULL
G	NULL
*~	NULL
3000	NULL
7	NULL
C	NULL
2	NULL
>	NULL
J	NULL
>	NULL
g	NULL
2000	NULL
7	NULL
o	NULL
Â®	NULL
ul	NULL
P	NULL
2	NULL
'	NULL
O	NULL
3	NULL
4	NULL
4000	NULL
0	NULL
2	NULL
3	NULL
o	NULL
(	NULL
4	NULL
0	NULL
1	NULL
20	NULL
80	NULL
Activation	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
B	NULL
400	NULL
C	NULL
Rol	NULL
s	NULL
S	NULL
C	NULL
C	NULL
2	NULL
2	NULL
3	NULL
&	NULL
-	NULL
200	NULL
o	NULL
A	NULL
fu	NULL
3	NULL
1	NULL
'	NULL
o	NULL
S	NULL
o	NULL
100	NULL
4	NULL
2	NULL
ts	NULL
Â®	NULL
[	NULL
+3	NULL
o	NULL
<	NULL
V	NULL
AW	NULL
4	NULL
VAW	NULL
4	NULL
'	NULL
APC/-	NULL
_	NULL
APC/sCTLA4Ig	NULL
ECDI-APC/-	NULL
-	NULL
APC	NULL
soluble	NULL
anti-CD3	NULL
immobilized	NULL
-	NULL
anti-CD3	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Costimulation	NULL
requirement	NULL
for	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
precursor	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Total	NULL
spleen	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10Â°	NULL
)	NULL
from	NULL
different	NULL
lines	NULL
of	NULL
NFAT-Lue	NULL
transgenic	NULL
mice	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
MAb	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
before	NULL
assay	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

(	NULL
B	NULL
)	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10Â°	NULL
)	NULL
from	NULL
Cyt	NULL
c	NULL
TCR	NULL
x	NULL
NFAT-Luc	NULL
double	NULL
transgenic	NULL
mice	NULL
were	NULL
purified	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
stimulated	NULL
with	NULL
(	NULL
i	NULL
)	NULL
soluble	NULL
anti-CD3	NULL
MAb	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
and	NULL
normal	NULL
APC	NULL
(	NULL
APC	NULL
)	NULL
or	NULL
ECDI-fixed	NULL
APC	NULL
(	NULL
ECDI-APC	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
the	NULL
presence	NULL
(	NULL
sCTLA4Ig	NULL
)	NULL
of	NULL
soluble	NULL
CTLA4-Ig	NULL
(	NULL
10	NULL
pg/m	NULL
!	NULL
)	NULL

or	NULL
(	NULL
ii	NULL
)	NULL
immobilized	NULL
anti-CD3	NULL
MAb	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
the	NULL
presence	NULL
(	NULL
APC	NULL
)	NULL
of	NULL
normal	NULL
APC	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
used	NULL
for	NULL
luciferase	NULL
activity	NULL
analysis	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
A	NULL
wash	NULL
|	NULL
--	NULL
-I	NULL
4	NULL
days	NULL
+ConA	NULL
or	NULL
pept	NULL
Â¥	NULL
effector	NULL
+APC	NULL
CD4*	NULL
T	NULL
cells	NULL
precursor	NULL
CD4+*	NULL
T	NULL
cells	NULL
B	NULL
15000	NULL
~	NULL
B	NULL
conaic4	NULL
&	NULL
0	NULL
E	NULL
]	NULL
ConML-12	NULL
6	NULL
3	NULL
C	NULL
5	NULL
kel	NULL
2	NULL
*	NULL
10000	NULL
&	NULL
>	NULL
6	NULL
<	NULL
@	NULL
#	NULL
&	NULL
2	NULL
Â§	NULL
5000	NULL
{	NULL
M	NULL
0	NULL
2	NULL
Â®	NULL
L	NULL
[	NULL
e	NULL
Activation	NULL
Time	NULL
(	NULL
days	NULL
)	NULL
4	NULL
h	NULL
3	NULL
days	NULL
4	NULL
days	NULL
=	NULL
-	NULL
ConA	NULL
ConA	NULL
IL-4	NULL
_	NULL
IL-12	NULL
ConA	NULL
ConA	NULL
ConA	NULL
ConA	NULL
IL-4	NULL
IL-12	NULL
IL-4	NULL
IL-12	NULL
M	NULL
M	NULL
(	NULL
50	NULL
)	NULL
.	NULL

To	NULL
establish	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
NFAT	NULL
induction	NULL
in	NULL
eTh2	NULL
cells	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
regulation	NULL
of	NULL
NFAT	NULL
activity	NULL
by	NULL
specific	NULL
antigen	NULL
.	NULL

Thus	NULL
,	NULL
Cyt	NULL
c	NULL
peptide	NULL
also	NULL
induced	NULL
high	NULL
levels	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
eTh2	NULL
cells	NULL
,	NULL
which	NULL
had	NULL
developed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
peptide	NULL
and	NULL
IL-4	NULL
with	NULL
Cyt	NULL
c	NULL
peptide	NULL
.	NULL

Peptide	NULL
restimulation	NULL
,	NULL
however	NULL
,	NULL
triggered	NULL
little	NULL
transcription	NULL
mediated	NULL
by	NULL
NFAT	NULL
in	NULL
eTh1	NULL
cells	NULL
differentiated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
peptide	NULL
and	NULL
IL-12	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

The	NULL
lower	NULL
levels	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
observed	NULL
after	NULL
12	NULL
h	NULL
of	NULL
stimulation	NULL
in	NULL
NFAT	NULL
TRANSCRIPTIONAL	NULL
ACTIVITY	NULL
IN	NULL
CD4+*	NULL
Th2	NULL
CELLS	NULL
1527	NULL
ConAÂ¥/	NULL
.	NULL

--	NULL
pept+APC	NULL
,	NULL
cytokines	NULL
#	NULL
/	NULL
/	NULL
_	NULL
___	NULL
.	NULL

NFAT	NULL
transcriptional	NULL
activity	NULL
*	NULL
~	NULL
~	NULL
~	NULL
NFAT	NULL
DNA	NULL
binding	NULL
ConA	NULL
)	NULL
pept+APC	NULL
C	NULL
4075	NULL
4000	NULL
7	NULL
R	NULL
pepuit-4	NULL
g	NULL
_-	NULL
EJ	NULL
peptiL-12	NULL
Â§	NULL
~	NULL
3	NULL
C	NULL
Â£	NULL
hig	NULL
Â£	NULL
z	NULL
a	NULL
S	NULL
yes	NULL
#	NULL
y*	NULL
0	NULL
%	NULL
<	NULL
1000	NULL
7	NULL
``	NULL
~	NULL
``	NULL
@	NULL
f	NULL
â	NULL
.	NULL

8	NULL
Ix	NULL
)	NULL
Â»	NULL
.	NULL

G	NULL
f\f\	NULL
.	NULL

3	NULL
Ass	NULL
o	NULL
â	NULL
\/\	NULL
2	NULL
nts	NULL
g	NULL
``	NULL
\	NULL
``	NULL
aC	NULL
.-\/\	NULL
.	NULL

\	NULL
``	NULL
#	NULL
.	NULL

2	NULL
~*~	NULL
xxxx	NULL
*	NULL
[	NULL
%	NULL
o	NULL
r	NULL
abe	NULL
FA	NULL
|7	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Activation	NULL
Time	NULL
(	NULL
days	NULL
)	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Regulation	NULL
of	NULL
NFAT	NULL
activity	NULL
during	NULL
differentiation	NULL
of	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Precursor	NULL
CD4*	NULL
T	NULL
cells	NULL
(	NULL
pTh	NULL
)	NULL
from	NULL
Cyt	NULL
c	NULL
TCR	NULL
X	NULL
NFAT-Lue	NULL
double	NULL
transgenic	NULL
mice	NULL
were	NULL
differentiated	NULL
,	NULL
with	NULL
ConA	NULL
(	NULL
2.5	NULL
pg/ml	NULL
)	NULL
or	NULL
Cyt	NULL
c	NULL
peptide	NULL
(	NULL
pept	NULL
)	NULL
(	NULL
5	NULL
g/m	NULL
!	NULL
)	NULL

and	NULL
APC	NULL
,	NULL
into	NULL
eTh2	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
(	NULL
10Â°	NULL
U/m	NULL
)	NULL
or	NULL
into	NULL
eTh2	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-12	NULL
(	NULL
3.5	NULL
ng/m	NULL
!	NULL
)	NULL

.	NULL

After	NULL
4	NULL
days	NULL
of	NULL
differenti-ation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
exhaustively	NULL
washed	NULL
and	NULL
restimulated	NULL
with	NULL
different	NULL
stimuli	NULL
before	NULL
harvest	NULL
and	NULL
analysis	NULL
for	NULL
cytokine	NULL
production	NULL
,	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
,	NULL
and	NULL
NFAT	NULL
DNA	NULL
binding	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
pTh	NULL
cells	NULL
into	NULL
eTh	NULL
cells	NULL
.	NULL

pTh	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10Â°	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
ConA	NULL
(	NULL
B	NULL
)	NULL
or	NULL
Cyt	NULL
c	NULL
peptide	NULL
(	NULL
C	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-12	NULL
,	NULL
as	NULL
described	NULL
for	NULL
panel	NULL
A.	NULL
Luciferase	NULL
activity	NULL
was	NULL
analyzed	NULL
after	NULL
different	NULL
periods	NULL
of	NULL
activation	NULL
.	NULL

(	NULL
D	NULL
)	NULL
NFAT	NULL
DNA	NULL
binding	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
pTh	NULL
cells	NULL
into	NULL
eTh	NULL
cells	NULL
.	NULL

pTh	NULL
cells	NULL
not	NULL
stimulated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
ConA	NULL
and	NULL
APC	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-4	NULL
or	NULL
IL-12	NULL
were	NULL
harvested	NULL
after	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
using	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
distal	NULL
NFAT	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
IL2-NFAT	NULL
)	NULL
.	NULL

eTh1	NULL
cells	NULL
relative	NULL
to	NULL
that	NULL
in	NULL
eTh2	NULL
cells	NULL
were	NULL
also	NULL
observed	NULL
after	NULL
24	NULL
h	NULL
of	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
and	NULL
C	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
NFAT	NULL
activity	NULL
induced	NULL
in	NULL
eTh1	NULL
cells	NULL
was	NULL
not	NULL
caused	NULL
by	NULL
delayed	NULL
kinetics	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
NFAT	NULL
can	NULL
mediate	NULL
transcription	NULL
in	NULL
eTh2	NULL
cells	NULL
but	NULL
to	NULL
a	NULL
much	NULL
lesser	NULL
extent	NULL
in	NULL
eTh1	NULL
cells	NULL
.	NULL

Since	NULL
studies	NULL
based	NULL
on	NULL
Th1	NULL
and	NULL
Th2	NULL
clones	NULL
indicate	NULL
that	NULL
IL-2	NULL
is	NULL
a	NULL
Thli-type	NULL
cytokine	NULL
,	NULL
our	NULL
data	NULL
seemed	NULL
at	NULL
first	NULL
sight	NULL
to	NULL
be	NULL
counterintuitive	NULL
because	NULL
they	NULL
suggested	NULL
that	NULL
NFAT	NULL
was	NULL
not	NULL
1528	NULL
RINCON	NULL
AND	NULL
FLAVELL	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
3000	NULL
-	NULL
200	NULL
7	NULL
A	NULL
iL4	NULL
N	NULL
IFN	NULL
7	NULL
A	NULL
iL4	NULL
m	NULL
FN	NULL
Y	NULL
5	NULL
2000	NULL
7	NULL
2	NULL
6	NULL
B	NULL
100	NULL
2	NULL
a	NULL
.	NULL

Â©	NULL
C	NULL
â¬	NULL
2	NULL
1000	NULL
7	NULL
>	NULL
~	NULL
0	NULL
0	NULL
0	NULL
eTh2	NULL
eThi	NULL
eTh2	NULL
eTh1	NULL
ConA	NULL
-	NULL
stimulation	NULL
peptide	NULL
|	NULL
stimulation	NULL
B	NULL
35000	NULL
-	NULL
2000007	NULL
179.375	NULL
33,520	NULL
:	NULL
MN	NULL
etTh2	NULL
{	NULL
eTh1	NULL
so000	NULL
4	NULL
>	NULL
sh	NULL
150000	NULL
{	NULL
&	NULL
10000	NULL
-	NULL
``	NULL
T	NULL
``	NULL
8	NULL
60000	NULL
7	NULL
Â©	NULL
2	NULL
o	NULL
3	NULL
PS	NULL
o	NULL
40000	NULL
>	NULL
Â®	NULL
5000	NULL
6	NULL
[	NULL
+4	NULL
20000	NULL
7	NULL
o	NULL
-	NULL
o	NULL
-	NULL
r	NULL
r	NULL
r	NULL
-	NULL
ConA	NULL
_	NULL
Y-antiCD3	NULL
P/	NULL
lon	NULL
PMA	NULL
-	NULL
ConA	NULL
Y-antiCD3	NULL
P/	NULL
lon	NULL
PMA	NULL
Restimulation	NULL
(	NULL
12	NULL
h	NULL
)	NULL
Restimulation	NULL
(	NULL
24	NULL
h	NULL
)	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Regulation	NULL
of	NULL
cytokine	NULL
production	NULL
and	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
during	NULL
activation	NULL
of	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
IL-4	NULL
and	NULL
IFN-y	NULL
production	NULL
in	NULL
effector	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

ConA-	NULL
or	NULL
peptide-differentiated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
(	NULL
as	NULL
described	NULL
for	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
were	NULL
restimulated	NULL
with	NULL
ConA	NULL
(	NULL
2.5	NULL
pg/ml	NULL
!	NULL
)	NULL

(	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
APC	NULL
)	NULL
or	NULL
peptide	NULL
(	NULL
5	NULL
ug/ml	NULL
!	NULL
)	NULL

plus	NULL
APC	NULL
,	NULL
respectively	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
analyzed	NULL
for	NULL
IL-4	NULL
and	NULL
IFN-y	NULL
production	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
.	NULL

(	NULL
B	NULL
)	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
effector	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

ConA-differentiated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
(	NULL
3	NULL
x	NULL
10Â°	NULL
)	NULL
were	NULL
restimulated	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
-	NULL
)	NULL
,	NULL
ConA	NULL
(	NULL
2.5	NULL
ug/ml	NULL
)	NULL
,	NULL
immobilized	NULL
anti-CD3	NULL
MAb	NULL
(	NULL
Y-antiCD3	NULL
)	NULL
(	NULL
5	NULL
ug/m	NULL
!	NULL
)	NULL

,	NULL
PMA	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
ionomycin	NULL
(	NULL
Ion	NULL
)	NULL
(	NULL
250	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
or	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
P/L	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
APC	NULL
.	NULL

After	NULL
12	NULL
or	NULL
24	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Cyt	NULL
c	NULL
peptide-differentiated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
(	NULL
3	NULL
x	NULL
10Â°	NULL
)	NULL
were	NULL
restimulated	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
-	NULL
)	NULL
or	NULL
Cyt	NULL
c	NULL
peptide	NULL
(	NULL
pept	NULL
)	NULL
(	NULL
5	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
12	NULL
or	NULL
24	NULL
h	NULL
before	NULL
harvest	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
.	NULL

(	NULL
D	NULL
)	NULL
IL-2	NULL
production	NULL
in	NULL
precursor	NULL
and	NULL
effector	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

pTh	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
ConA	NULL
(	NULL
2.5	NULL
pg/ml	NULL
)	NULL
or	NULL
Cyt	NULL
c	NULL
peptide	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
APC	NULL
plus	NULL
IL-4	NULL
(	NULL
10Â°	NULL
U/ml	NULL
)	NULL
or	NULL
IL-12	NULL
(	NULL
3.5	NULL
ng/ml	NULL
)	NULL
for	NULL
24	NULL
h	NULL
(	NULL
Primary	NULL
stimulation	NULL
)	NULL
.	NULL

ConA	NULL
Â»	NULL
or	NULL
peptide-differentiated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
were	NULL
restimulated	NULL
with	NULL
ConA	NULL
(	NULL
2.5	NULL
ug/ml	NULL
!	NULL
)	NULL

or	NULL
peptide	NULL
(	NULL
5	NULL
g/m	NULL
!	NULL
)	NULL

for	NULL
24	NULL
h	NULL
(	NULL
restimulation	NULL
)	NULL
.	NULL

Supernatants	NULL
from	NULL
the	NULL
different	NULL
cultures	NULL
were	NULL
collected	NULL
and	NULL
analyzed	NULL
for	NULL
IL-2	NULL
production	NULL
by	NULL
a	NULL
biological	NULL
assay	NULL
.	NULL

(	NULL
E	NULL
)	NULL
Effect	NULL
of	NULL
costimulation	NULL
on	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
induced	NULL
in	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

ConA-differentiated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
(	NULL
3	NULL
x	NULL
10Â°	NULL
)	NULL
were	NULL
restimulated	NULL
with	NULL
ConA	NULL
(	NULL
2.5	NULL
ug/ml	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
APC	NULL
(	NULL
1.5	NULL
x	NULL
10Â°	NULL
)	NULL
.	NULL

After	NULL
12	NULL
h	NULL
cells	NULL
were	NULL
harvested	NULL
to	NULL
analyze	NULL
luciferase	NULL
activity	NULL
.	NULL

Relative	NULL
Luciferase	NULL
Activity	NULL
5000	NULL
7	NULL
4000	NULL
7	NULL
3000	NULL
2000	NULL
7	NULL
1000	NULL
7	NULL
IL-2	NULL
production	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
500	NULL
7	NULL
400	NULL
7	NULL
300	NULL
7	NULL
200	NULL
7	NULL
100	NULL
7	NULL
NM	NULL
eTh2	NULL
C	NULL
eThi	NULL
pept	NULL
3	NULL
202020909	NULL
%	NULL
%	NULL
8	NULL
%	NULL
*	NULL
80A	NULL
%	NULL
200000909	NULL
NUR	NULL
O8	NULL
OA	NULL
L	NULL
202	NULL
2022	NULL
%	NULL
o	NULL
%	NULL
%	NULL
%	NULL
%	NULL
%	NULL
2.2020	NULL
A	NULL
(	NULL
8808	NULL
*	NULL
%	NULL
%	NULL
202020902	NULL
a	NULL
A	NULL
%	NULL
8	NULL
%	NULL
J	NULL
AJ	NULL
#	NULL
,	NULL
0000909	NULL
&	NULL
2.9	NULL
Ln	NULL
mn	NULL
Wha	NULL
A	NULL
%	NULL
ACACACAL	NULL
4	NULL
#	NULL
02	NULL
80	NULL
%	NULL
und	NULL
202	NULL
,	NULL
a	NULL
)	NULL
a	NULL
)	NULL
2	NULL
a	NULL
20+	NULL
OA	NULL
OA	NULL
Aus	NULL
%	NULL
%	NULL
202	NULL
2020	NULL
Â¢	NULL
#	NULL
2.2	NULL
%	NULL
%	NULL
Und	NULL
%	NULL
%	NULL
202020202	NULL
#	NULL
CALs	NULL
%	NULL
A	NULL
OA	NULL
*	NULL
%	NULL
%	NULL
2,209	NULL
)	NULL
9	NULL
L	NULL
#	NULL
,	NULL
2	NULL
AoA	NULL
O8	NULL
U8	NULL
J	NULL
%	NULL
%	NULL
CALACALA	NULL
2	NULL
#	NULL
.	NULL

Â¢	NULL
AoA	NULL
O8	NULL
OX	NULL
RoX	NULL
NOX	NULL
*	NULL
#	NULL
.	NULL

2	NULL
Sox	NULL
ORCA	NULL
Bos	NULL
U8	NULL
2020902	NULL
#	NULL
20+	NULL
0	NULL
%	NULL
0	NULL
%	NULL
*	NULL
%	NULL
LMJ	NULL
#	NULL
020202	NULL
&	NULL
2.2	NULL
NOA	NULL
O8	NULL
C8	NULL
Aus	NULL
AA	NULL
2020202	NULL
a	NULL
202	NULL
%	NULL
%	NULL
08	NULL
%	NULL
%	NULL
A	NULL
200909	NULL
G	NULL
Laks	NULL
A88	NULL
Ro	NULL
A	NULL
%	NULL
2.20009	NULL
#	NULL
#	NULL
09	NULL
NOR	NULL
8,8	NULL
W	NULL
%	NULL
%	NULL
%	NULL
#	NULL
202	NULL
U8	NULL
8	NULL
%	NULL
WJ	NULL
AJ	NULL
#	NULL
.	NULL

00009	NULL
a	NULL
202	NULL
NUR	NULL
O8	NULL
,	NULL
A	NULL
Bos	NULL
L	NULL
202	NULL
)	NULL
202	NULL
*	NULL
Cals	NULL
O8	NULL
CA	NULL
J	NULL
%	NULL
(	NULL
%	NULL
2.20902	NULL
a	NULL
Cals	NULL
:	NULL
&	NULL
&	NULL
&	NULL
&	NULL
%	NULL
%	NULL
~	NULL
&	NULL
&	NULL
&	NULL
&	NULL
%	NULL
ConA/iL4	NULL
-	NULL
ConA/IL12	NULL
eTha	NULL
eThi	NULL
pept/IL4	NULL
-	NULL
pept/lL12	NULL
eTh2	NULL
eThi	NULL
Primary	NULL
stimulation	NULL
(	NULL
pTh	NULL
cells	NULL
)	NULL
ConA	NULL
restimulation	NULL
Primary	NULL
stimulation	NULL
(	NULL
pTh	NULL
cells	NULL
)	NULL
peptide	NULL
restimulation	NULL
ConA	NULL
Restimulation	NULL
ConA/APC	NULL
1529	NULL
required	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
IL-2	NULL
in	NULL
eTh1	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
analysis	NULL
of	NULL
IL-2	NULL
production	NULL
showed	NULL
that	NULL
only	NULL
low	NULL
levels	NULL
of	NULL
IL-2	NULL
were	NULL
produced	NULL
in	NULL
either	NULL
eTh2	NULL
or	NULL
eTh1	NULL
cells	NULL
stimulated	NULL
with	NULL
ConA	NULL
or	NULL
with	NULL
Cyt	NULL
c	NULL
peptide	NULL
,	NULL
while	NULL
high	NULL
levels	NULL
of	NULL
IL-2	NULL
were	NULL
detected	NULL
in	NULL
pTh	NULL
cells	NULL
24	NULL
h	NULL
after	NULL
stimulation	NULL
with	NULL
ConA	NULL
and	NULL
significant	NULL
levels	NULL
were	NULL
found	NULL
after	NULL
stimulation	NULL
with	NULL
peptide	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
IL-2	NULL
was	NULL
equally	NULL
expressed	NULL
during	NULL
the	NULL
activation	NULL
of	NULL
pTh	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
IL-4	NULL
or	NULL
IL-12	NULL
,	NULL
but	NULL
it	NULL
was	NULL
not	NULL
expressed	NULL
significantly	NULL
in	NULL
activated	NULL
eTh1	NULL
cells	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
detectable	NULL
IL-2	NULL
in	NULL
eTh1	NULL
cells	NULL
was	NULL
not	NULL
due	NULL
to	NULL
the	NULL
consumption	NULL
of	NULL
IL-2	NULL
by	NULL
the	NULL
eTh1	NULL
cells	NULL
,	NULL
because	NULL
very	NULL
low	NULL
IL-2	NULL
mRNA	NULL
levels	NULL
were	NULL
detected	NULL
in	NULL
eTh1	NULL
cells	NULL
compared	NULL
to	NULL
those	NULL
induced	NULL
in	NULL
pTh	NULL
cells	NULL
(	NULL
41a	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
costimulation	NULL
that	NULL
was	NULL
required	NULL
to	NULL
induce	NULL
NFAT	NULL
activity	NULL
in	NULL
pTh	NULL
cells	NULL
(	NULL
see	NULL
above	NULL
)	NULL
,	NULL
ConA	NULL
or	NULL
immobilized	NULL
anti-CD3	NULL
MAb	NULL
alone	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
APC	NULL
,	NULL
was	NULL
able	NULL
to	NULL
stimulate	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
eTh2	NULL
cells	NULL
,	NULL
showing	NULL
that	NULL
this	NULL
second	NULL
signal	NULL
was	NULL
not	NULL
required	NULL
in	NULL
effector	NULL
cells	NULL
.	NULL

Activation	NULL
of	NULL
Th1	NULL
cells	NULL
has	NULL
been	NULL
described	NULL
to	NULL
be	NULL
more	NULL
dependent	NULL
on	NULL
costimulation	NULL
than	NULL
the	NULL
activation	NULL
of	NULL
Th2	NULL
cells	NULL
.	NULL

It	NULL
was	NULL
there	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

1530	NULL
RINCON	NULL
AND	NULL
FLAVELL	NULL
A	NULL
B	NULL
eTh2	NULL
eTh1	NULL
eTh	NULL
?	NULL

2	NULL
eTh1	NULL
~	NULL
ConA	NULL
.	NULL

.-	NULL
ConA	NULL
-	NULL
_	NULL
NFATp	NULL
NFATe	NULL
-	NULL
_	NULL
NFATp	NULL
NFAT	NULL
NFAT	NULL
**	NULL
wo	NULL
)	NULL
-	NULL
pad	NULL
eTh2	NULL
eTh1	NULL
*	NULL
_	NULL
ConA	NULL
~	NULL
_	NULL
ConA	NULL
kx	NULL
CREB	NULL
weep	NULL
C	NULL
unstimulated	NULL
ConA	NULL
eTha	NULL
eTh1	NULL
eTh2	NULL
eTh1	NULL
-	NULL
_	NULL
NFATp	NULL
NFATe	NULL
-	NULL
_	NULL
NFATp	NULL
NFAT	NULL
â	NULL
|	NULL
ma	NULL
HB	NULL
#	NULL
misa	NULL
NFATp	NULL
NFATcNFATp	NULL
'	NULL
-	NULL
_	NULL
NFATp	NULL
NFAT	NULL
NFATp	NULL
'	NULL
&	NULL
=	NULL
awet	NULL
Â§	NULL
Â«	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
nature	NULL
of	NULL
NFAT	NULL
complexes	NULL
in	NULL
ConA-differentiated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
extracts	NULL
from	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
not	NULL
stimulated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
ConA	NULL
(	NULL
2.5	NULL
pg/ml	NULL
)	NULL
for	NULL
3	NULL
h	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
by	NULL
using	NULL
an	NULL
IL2-NFAT	NULL
oligonucleotide	NULL
(	NULL
NFAT	NULL
)	NULL
or	NULL
a	NULL
CRE	NULL
oligonucleotide	NULL
(	NULL
CREB	NULL
)	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
extracts	NULL
from	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
stimulated	NULL
with	NULL
ConA	NULL
for	NULL
3	NULL
h	NULL
were	NULL
analyzed	NULL
with	NULL
an	NULL
IL2-NFAT	NULL
oligonucleotide	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-glutathione	NULL
S-transferase	NULL
(	NULL
-	NULL
)	NULL
(	NULL
1	NULL
p	NULL
)	NULL
(	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
)	NULL
,	NULL
anti-NFATp	NULL
(	NULL
0.2	NULL
pl	NULL
)	NULL
,	NULL
or	NULL
anti-NFATc	NULL
(	NULL
1.5	NULL
pl	NULL
)	NULL
antisera	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
or	NULL
ConA-stimulated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
using	NULL
an	NULL
NFAT	NULL
binding	NULL
site	NULL
(	NULL
-60	NULL
to	NULL
-83	NULL
)	NULL
sequence	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
(	NULL
ILA-NFAT	NULL
oligonucleotide	NULL
)	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
antisera	NULL
described	NULL
for	NULL
panel	NULL
B	NULL
or	NULL
an	NULL
anti-NFATp	NULL
antiserum	NULL
from	NULL
an	NULL
alternative	NULL
source	NULL
(	NULL
NFATp	NULL
'	NULL
)	NULL
(	NULL
1	NULL
pl	NULL
)	NULL
.	NULL

fore	NULL
possible	NULL
that	NULL
this	NULL
caused	NULL
the	NULL
lack	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
that	NULL
we	NULL
observed	NULL
in	NULL
eTh1	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
APC	NULL
during	NULL
ConA	NULL
stimulation	NULL
did	NULL
not	NULL
increase	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
eTh1	NULL
cells	NULL
,	NULL
nor	NULL
did	NULL
it	NULL
modify	NULL
the	NULL
activity	NULL
of	NULL
eTh2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4E	NULL
)	NULL
.	NULL

Similar	NULL
cytoplasmic	NULL
components	NULL
of	NULL
NFAT	NULL
complexes	NULL
in	NULL
activated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
lack	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
eThl	NULL
cells	NULL
was	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
NFAT	NULL
complexes	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
we	NULL
examined	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

We	NULL
quantitated	NULL
the	NULL
levels	NULL
of	NULL
NFAT	NULL
complexes	NULL
using	NULL
densitometry	NULL
and	NULL
comparison	NULL
to	NULL
CREB	NULL
controls	NULL
in	NULL
the	NULL
same	NULL
extracts	NULL
.	NULL

Although	NULL
low	NULL
levels	NULL
of	NULL
NFAT	NULL
were	NULL
already	NULL
present	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
unstimulated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
,	NULL
after	NULL
stimulation	NULL
with	NULL
ConA	NULL
upregulation	NULL
occurred	NULL
to	NULL
similar	NULL
levels	NULL
in	NULL
both	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
for	NULL
extraction	NULL
procedures	NULL
and	NULL
to	NULL
exclude	NULL
prote-olysis	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
DNA	NULL
binding	NULL
for	NULL
the	NULL
CREB	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

SA	NULL
)	NULL
.	NULL

In	NULL
some	NULL
of	NULL
the	NULL
experiments	NULL
we	NULL
observed	NULL
a	NULL
slightly	NULL
lower	NULL
(	NULL
1.5-	NULL
to	NULL
2-fold	NULL
)	NULL
NFAT	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
stimulated	NULL
eTh1	NULL
cells	NULL
.	NULL

Although	NULL
such	NULL
a	NULL
small	NULL
difference	NULL
could	NULL
explain	NULL
the	NULL
large	NULL
difference	NULL
in	NULL
NFAT	NULL
activity	NULL
between	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
(	NULL
15	NULL
)	NULL
,	NULL
we	NULL
think	NULL
it	NULL
is	NULL
equally	NULL
or	NULL
more	NULL
likely	NULL
that	NULL
secondary	NULL
modification	NULL
of	NULL
NFAT	NULL
or	NULL
an	NULL
associated	NULL
factor	NULL
can	NULL
ex	NULL
plain	NULL
these	NULL
data	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
nuclear	NULL
NFAT	NULL
complexes	NULL
were	NULL
present	NULL
and	NULL
could	NULL
bind	NULL
DNA	NULL
but	NULL
could	NULL
not	NULL
mediate	NULL
transcription	NULL
in	NULL
eTh1	NULL
cells	NULL
.	NULL

Different	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
21	NULL
,	NULL
23	NULL
,	NULL
37	NULL
,	NULL
38	NULL
,	NULL
43	NULL
)	NULL
,	NULL
but	NULL
the	NULL
function	NULL
and	NULL
the	NULL
relevance	NULL
of	NULL
each	NULL
one	NULL
of	NULL
these	NULL
members	NULL
in	NULL
the	NULL
transcriptional	NULL
activity	NULL
mediated	NULL
by	NULL
specific	NULL
NFAT	NULL
regulatory	NULL
elements	NULL
are	NULL
not	NULL
clear	NULL
.	NULL

Different	NULL
compositions	NULL
of	NULL
the	NULL
NFAT	NULL
complexes	NULL
detected	NULL
in	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
could	NULL
in	NULL
principle	NULL
account	NULL
for	NULL
the	NULL
differences	NULL
in	NULL
the	NULL
transcriptional	NULL
activity	NULL
.	NULL

We	NULL
therefore	NULL
analyzed	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
NFAT	NULL
complexes	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

It	NULL
has	NULL
been	NULL
previously	NULL
found	NULL
that	NULL
NFAT	NULL
3	NULL
is	NULL
expressed	NULL
,	NULL
at	NULL
the	NULL
level	NULL
of	NULL
RNA	NULL
,	NULL
principally	NULL
in	NULL
nonlymphoid	NULL
tissues	NULL
,	NULL
while	NULL
the	NULL
highest	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
NFAT	NULL
4	NULL
are	NULL
detected	NULL
in	NULL
thymus	NULL
(	NULL
21	NULL
,	NULL
23	NULL
,	NULL
37	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
expression	NULL
of	NULL
NFATp	NULL
and	NULL
NFATc	NULL
is	NULL
mostly	NULL
restricted	NULL
to	NULL
spleen	NULL
and	NULL
lymph	NULL
nodes	NULL
(	NULL
38	NULL
,	NULL
43	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
are	NULL
the	NULL
major	NULL
forms	NULL
of	NULL
NFAT	NULL
present	NULL
in	NULL
mature	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
the	NULL
presence	NULL
of	NULL
these	NULL
two	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
complexes	NULL
from	NULL
ConA-stimulated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

Only	NULL
one	NULL
NFAT	NULL
complex	NULL
was	NULL
detected	NULL
in	NULL
unstimulated	NULL
eTh1	NULL
or	NULL
eTh2	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
two	NULL
components	NULL
with	NULL
different	NULL
electrophoretic	NULL
mobilities	NULL
were	NULL
present	NULL
upon	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
anti-NFATp	NULL
antiserum	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
supershifted	NULL
the	NULL
upper	NULL
component	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
lower	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
component	NULL
in	NULL
stimulated	NULL
effector	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
anti-NFATc	NULL
antiserum	NULL
completely	NULL
abolished	NULL
the	NULL
faster-migrating	NULL
complex	NULL
,	NULL
while	NULL
it	NULL
competed	NULL
only	NULL
partially	NULL
the	NULL
upper	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicated	NULL
that	NULL
the	NULL
lower	NULL
NFAT	NULL
complex	NULL
present	NULL
in	NULL
stimulated	NULL
effector	NULL
cells	NULL
contained	NULL
mostly	NULL
NFATe	NULL
and	NULL
the	NULL
upper	NULL
complex	NULL
contained	NULL
NFATp	NULL
but	NULL
not	NULL
much	NULL
NFATe	NULL
.	NULL

However	NULL
,	NULL
no	NULL
difference	NULL
in	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
NFAT	NULL
DNA	NULL
binding	NULL
complexes	NULL
was	NULL
observed	NULL
between	NULL
stimulated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

It	NULL
seemed	NULL
that	NULL
the	NULL
degree	NULL
of	NULL
competition	NULL
of	NULL
the	NULL
upper	NULL
complex	NULL
with	NULL
anti-NFATc	NULL
antiserum	NULL
was	NULL
slightly	NULL
higher	NULL
in	NULL
stimulated	NULL
eTh1	NULL
cells	NULL
than	NULL
in	NULL
eTh2	NULL
cells	NULL
,	NULL
but	NULL
we	NULL
did	NULL
not	NULL
consider	NULL
this	NULL
difference	NULL
to	NULL
be	NULL
significant	NULL
enough	NULL
to	NULL
account	NULL
for	NULL
the	NULL
differences	NULL
observed	NULL
in	NULL
the	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

All	NULL
the	NULL
DNA	NULL
binding	NULL
analyses	NULL
described	NULL
above	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
double-strand	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
ILZ2-NFAT	NULL
)	NULL
(	NULL
which	NULL
was	NULL
used	NULL
to	NULL
generated	NULL
the	NULL
reporter	NULL
transgenic	NULL
mice	NULL
)	NULL
.	NULL

We	NULL
decided	NULL
to	NULL
examine	NULL
the	NULL
specific	NULL
DNA	NULL
binding	NULL
in	NULL
differentiated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
by	NULL
using	NULL
also	NULL
the	NULL
most	NULL
characterized	NULL
NFAT	NULL
site	NULL
(	NULL
-60	NULL
to	NULL
-83	NULL
)	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
(	NULL
IL4-NFAT	NULL
)	NULL
,	NULL
since	NULL
IL-4	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
eTh2	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
no	NULL
significant	NULL
differences	NULL
were	NULL
expected	NULL
since	NULL
previous	NULL
studies	NULL
with	NULL
Th1	NULL
and	NULL
Th2	NULL
clones	NULL
showed	NULL
similar	NULL
subunit	NULL
compositions	NULL
between	NULL
IL2-NFAT	NULL
and	NULL
IL4-NFAT	NULL
complexes	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
complexes	NULL
bound	NULL
to	NULL
the	NULL
IL4-NFAT	NULL
site	NULL
and	NULL
found	NULL
that	NULL
the	NULL
gel	NULL
profiles	NULL
were	NULL
identical	NULL
to	NULL
those	NULL
observed	NULL
with	NULL
the	NULL
IL2-NFAT	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
only	NULL
the	NULL
upper	NULL
band	NULL
was	NULL
detected	NULL
in	NULL
unstimulated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cell	NULL
extracts	NULL
,	NULL
and	NULL
it	NULL
was	NULL
competed	NULL
by	NULL
anti-NFATp	NULL
but	NULL
not	NULL
anti-NFATe	NULL
antisera	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Like	NULL
IL2-NFAT	NULL
complexes	NULL
,	NULL
upon	NULL
ConA	NULL
stimulation	NULL
of	NULL
both	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
,	NULL
a	NULL
faster-migrating	NULL
component	NULL
which	NULL
was	NULL
completely	NULL
competed	NULL
with	NULL
anti-NFATc	NULL
antiserum	NULL
was	NULL
also	NULL
induced	NULL
.	NULL

Two	NULL
different	NULL
antisera	NULL
against	NULL
anti-NFATp	NULL
failed	NULL
to	NULL
inhibit	NULL
the	NULL
binding	NULL
of	NULL
this	NULL
lower	NULL
component	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
component	NULL
of	NULL
NFAT	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
contain	NULL
some	NULL
AP-1	NULL
members	NULL
,	NULL
and	NULL
AP-1-like	NULL
sites	NULL
are	NULL
found	NULL
next	NULL
to	NULL
the	NULL
core	NULL
NFAT	NULL
binding	NULL
site	NULL
for	NULL
both	NULL
the	NULL
IL2-	NULL
and	NULL
IL4-NFAT	NULL
sequences	NULL
(	NULL
4	NULL
,	NULL
9	NULL
,	NULL
27	NULL
,	NULL
44	NULL
,	NULL
49	NULL
)	NULL
.	NULL

It	NULL
was	NULL
therefore	NULL
possible	NULL
that	NULL
although	NULL
no	NULL
differences	NULL
were	NULL
detected	NULL
in	NULL
the	NULL
cytoplasmic	NULL
component	NULL
of	NULL
the	NULL
NFAT	NULL
complex	NULL
,	NULL
differences	NULL
in	NULL
the	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
account	NULL
for	NULL
the	NULL
high	NULL
transcriptional	NULL
activity	NULL
induced	NULL
in	NULL
eTh2	NULL
but	NULL
not	NULL
eTh1	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
no	NULL
competition	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
IL4-NFAT	NULL
complexes	NULL
to	NULL
DNA	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
unlabeled	NULL
oligonucleotide	NULL
with	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
from	NULL
the	NULL
collagenase	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
or	NULL
metallothionein	NULL
promoter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Unlabeled	NULL
ILA-NFAT	NULL
and	NULL
IL2-NFAT	NULL
oligonucleotides	NULL
completely	NULL
inhibited	NULL
DNA	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Identical	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
the	NULL
IL2-NFAT	NULL
sequence	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
the	NULL
EMSA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggested	NULL
that	NULL
under	NULL
our	NULL
experimental	NULL
conditions	NULL
AP-1	NULL
components	NULL
were	NULL
not	NULL
detected	NULL
associated	NULL
with	NULL
NFAT	NULL
and	NULL
that	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
NFAT	NULL
complexes	NULL
from	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cell	NULL
extracts	NULL
does	NULL
not	NULL
require	NULL
the	NULL
AP-1	NULL
regulatory	NULL
element	NULL
.	NULL

As	NULL
a	NULL
further	NULL
control	NULL
,	NULL
we	NULL
also	NULL
analyzed	NULL
NFAT	NULL
DNA	NULL
binding	NULL
in	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
and	NULL
D10	NULL
(	NULL
a	NULL
CD4*	NULL
Th2	NULL
clone	NULL
)	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
but	NULL
unlabeled	NULL
AP-1	NULL
oligonucleotide	NULL
could	NULL
not	NULL
compete	NULL
NFAT	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
sequence	NULL
from	NULL
-60	NULL
to	NULL
-83	NULL
originally	NULL
identified	NULL
as	NULL
a	NULL
core	NULL
for	NULL
NFAT	NULL
binding	NULL
in	NULL
the	NULL
IL-4	NULL
promoter	NULL
,	NULL
an	NULL
upstream	NULL
element	NULL
(	NULL
-84	NULL
to	NULL
-91	NULL
)	NULL
has	NULL
also	NULL
been	NULL
described	NULL
more	NULL
recently	NULL
to	NULL
be	NULL
required	NULL
to	NULL
mediate	NULL
transcription	NULL
(	NULL
54	NULL
,	NULL
63	NULL
)	NULL
and	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
an	NULL
AP-1-related	NULL
protein	NULL
.	NULL

We	NULL
therefore	NULL
probed	NULL
for	NULL
the	NULL
differences	NULL
in	NULL
NFAT	NULL
DNA	NULL
binding	NULL
in	NULL
NFAT	NULL
TRANSCRIPTIONAL	NULL
ACTIVITY	NULL
IN	NULL
CD4+*	NULL
Th2	NULL
CELLS	NULL
|	NULL
1531	NULL
A	NULL
eTh2	NULL
eTh1	NULL
IL4	NULL
_	NULL
IL2	NULL
IL4	NULL
_	NULL
IL2	NULL
-	NULL
-	NULL
AP1	NULL
NFAT	NULL
NFAT	NULL
.	NULL

AP1	NULL
-	NULL
NFAT	NULL
NFAT	NULL
=	NULL
AP1	NULL
JK	NULL
-	NULL
D10	NULL
JK	NULL
_	NULL
D10	NULL
c	NULL
anti	NULL
=	NULL
NFATp	NULL
AP1	NULL
eTh2	NULL
eTh1i	NULL
eTh2	NULL
eTh1	NULL
eTh2	NULL
eThi	NULL
#	NULL
#	NULL
4	NULL
woe	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
AP-1	NULL
component	NULL
in	NULL
the	NULL
NFAT	NULL
complexes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
extracts	NULL
from	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
stimulated	NULL
with	NULL
ConA	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
by	NULL
using	NULL
the	NULL
ILA-NFAT	NULL
oligonucleotide	NULL
probe	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
excess	NULL
(	NULL
100-fold	NULL
)	NULL
of	NULL
cold	NULL
collagenase	NULL
AP-1	NULL
,	NULL
IL2-NFAT	NULL
,	NULL
or	NULL
IL4-NFAT	NULL
oligonucleotide	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
(	NULL
JK	NULL
)	NULL
cells	NULL
or	NULL
D10	NULL
cells	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
5	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
ionomycin	NULL
(	NULL
250	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
3	NULL
h	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
by	NULL
using	NULL
the	NULL
ILA4-NFAT	NULL
oligonucleotide	NULL
probe	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
excess	NULL
(	NULL
100-fold	NULL
)	NULL
of	NULL
cold	NULL
collagenase	NULL
AP-1	NULL
oligonucleotide	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Nuclear	NULL
extracts	NULL
from	NULL
ConA-stimulated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
using	NULL
a	NULL
longer	NULL
sequence	NULL
(	NULL
-60	NULL
to	NULL
-91	NULL
)	NULL
of	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
IL-4	NULL
promoter	NULL
(	NULL
long	NULL
ILA-NFAT	NULL
)	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-NFATp	NULL
antiserum	NULL
(	NULL
0.2	NULL
pl	NULL
)	NULL
or	NULL
an	NULL
excess	NULL
(	NULL
100-fold	NULL
)	NULL
of	NULL
cold	NULL
AP-1	NULL
oligonucleotide	NULL
(	NULL
AP1	NULL
)	NULL
.	NULL

stimulated	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
,	NULL
by	NULL
using	NULL
a	NULL
longer	NULL
NFAT	NULL
oligonucleotide	NULL
which	NULL
contained	NULL
this	NULL
upstream	NULL
sequence	NULL
(	NULL
-60	NULL
to	NULL
-91	NULL
)	NULL
.	NULL

No	NULL
differences	NULL
were	NULL
found	NULL
between	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cell	NULL
complexes	NULL
,	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
cold	NULL
AP-1	NULL
oligonucleotide	NULL
did	NULL
not	NULL
modify	NULL
the	NULL
NFAT	NULL
DNA	NULL
binding	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
lower	NULL
component	NULL
was	NULL
stronger	NULL
with	NULL
the	NULL
longer	NULL
1532	NULL
RINCON	NULL
AND	NULL
FLAVELL	NULL
IL4-NFAT	NULL
sequence	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
upstream	NULL
sequences	NULL
are	NULL
also	NULL
involved	NULL
and	NULL
favor	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
NFATc	NULL
protein	NULL
.	NULL

DISCUSSION	NULL
Although	NULL
NFAT	NULL
was	NULL
originally	NULL
associated	NULL
specifically	NULL
with	NULL
the	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
transcription	NULL
,	NULL
NFAT	NULL
DNA	NULL
binding	NULL
has	NULL
also	NULL
been	NULL
detected	NULL
in	NULL
activated	NULL
lymphoid	NULL
cells	NULL
other	NULL
than	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
NFAT	NULL
regulatory	NULL
elements	NULL
have	NULL
been	NULL
found	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
many	NULL
cytokines	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NFAT	NULL
is	NULL
a	NULL
family	NULL
of	NULL
several	NULL
related	NULL
proteins	NULL
which	NULL
are	NULL
distributed	NULL
differentially	NULL
in	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
tissues	NULL
.	NULL

Due	NULL
to	NULL
this	NULL
redundancy	NULL
and	NULL
to	NULL
the	NULL
paucity	NULL
of	NULL
information	NULL
that	NULL
is	NULL
available	NULL
about	NULL
the	NULL
relevance	NULL
of	NULL
each	NULL
of	NULL
these	NULL
NFAT	NULL
proteins	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
transcription	NULL
mediated	NULL
by	NULL
NFAT	NULL
during	NULL
the	NULL
immune	NULL
response	NULL
remains	NULL
unclear	NULL
.	NULL

We	NULL
therefore	NULL
developed	NULL
a	NULL
highly	NULL
sensitive	NULL
system	NULL
(	NULL
NFAT-Luc	NULL
reporter	NULL
transgenic	NULL
mice	NULL
)	NULL
to	NULL
analyze	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
during	NULL
the	NULL
development	NULL
of	NULL
the	NULL
mouse	NULL
immune	NULL
system	NULL
and	NULL
during	NULL
the	NULL
activation	NULL
and	NULL
differentiation	NULL
of	NULL
primary	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
antigens	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
described	NULL
the	NULL
regulation	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
during	NULL
thymic	NULL
development	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
the	NULL
regulation	NULL
and	NULL
signal	NULL
requirement	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activities	NULL
of	NULL
NFAT	NULL
,	NULL
first	NULL
,	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
precursor	NULL
T	NULL
cells	NULL
and	NULL
,	NULL
second	NULL
,	NULL
in	NULL
the	NULL
differentiation	NULL
and	NULL
activation	NULL
of	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

Confirming	NULL
previous	NULL
reports	NULL
using	NULL
transgenic	NULL
mice	NULL
(	NULL
67	NULL
)	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
is	NULL
induced	NULL
in	NULL
both	NULL
normal	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
upon	NULL
stimulation	NULL
and	NULL
was	NULL
dependent	NULL
on	NULL
both	NULL
Ca**	NULL
and	NULL
PKC	NULL
signals	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
demonstrated	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
activation	NULL
via	NULL
the	NULL
TCR	NULL
signal	NULL
was	NULL
not	NULL
sufficient	NULL
to	NULL
induce	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
precursor	NULL
T	NULL
cells	NULL
and	NULL
that	NULL
a	NULL
costimulatory	NULL
signal	NULL
was	NULL
also	NULL
required	NULL
.	NULL

This	NULL
costimulatory	NULL
signal	NULL
was	NULL
mediated	NULL
,	NULL
at	NULL
least	NULL
partially	NULL
,	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
CD28/CTLA-4	NULL
with	NULL
B7.1/B7.2	NULL
on	NULL
the	NULL
APC	NULL
,	NULL
although	NULL
we	NULL
can	NULL
not	NULL
eliminate	NULL
the	NULL
possibility	NULL
that	NULL
other	NULL
costimulatory	NULL
molecules	NULL
are	NULL
also	NULL
involved	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
however	NULL
,	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
did	NULL
not	NULL
require	NULL
costimulation	NULL
in	NULL
eTh2	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
signal	NULL
mediated	NULL
by	NULL
the	NULL
TCR	NULL
induced	NULL
much	NULL
higher	NULL
NFAT	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
than	NULL
in	NULL
precursor	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
requirements	NULL
correlated	NULL
with	NULL
the	NULL
signal	NULL
requirements	NULL
associated	NULL
with	NULL
a	NULL
particular	NULL
stage	NULL
of	NULL
differentiation	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
activation	NULL
of	NULL
precursor	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
results	NULL
in	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
,	NULL
which	NULL
is	NULL
strictly	NULL
dependent	NULL
on	NULL
costimulation	NULL
(	NULL
41	NULL
)	NULL
,	NULL
whereas	NULL
a	NULL
TCR-mediated	NULL
signal	NULL
is	NULL
sufficient	NULL
to	NULL
induce	NULL
IL-4	NULL
production	NULL
in	NULL
eTh2	NULL
.	NULL

We	NULL
have	NULL
also	NULL
observed	NULL
similar	NULL
modifications	NULL
in	NULL
the	NULL
signal	NULL
requirement	NULL
for	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
reprogramming	NULL
of	NULL
the	NULL
signal	NULL
requirement	NULL
for	NULL
a	NULL
given	NULL
effector	NULL
function	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
IL-2	NULL
versus	NULL
IL-4	NULL
production	NULL
)	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
pTh	NULL
cells	NULL
into	NULL
eTh	NULL
cells	NULL
is	NULL
due	NULL
to	NULL
the	NULL
reprogramming	NULL
for	NULL
the	NULL
signals	NULL
needed	NULL
to	NULL
activate	NULL
specific	NULL
transcriptional	NULL
factors	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
distinction	NULL
between	NULL
the	NULL
two	NULL
kinds	NULL
of	NULL
effector	NULL
cells	NULL
,	NULL
eTh1	NULL
and	NULL
eTh2	NULL
,	NULL
remains	NULL
unknown	NULL
,	NULL
but	NULL
differences	NULL
in	NULL
the	NULL
transcriptional	NULL
system	NULL
that	NULL
directs	NULL
the	NULL
expression	NULL
of	NULL
certain	NULL
cytokines	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
important	NULL
.	NULL

This	NULL
question	NULL
has	NULL
been	NULL
previously	NULL
approached	NULL
by	NULL
others	NULL
(	NULL
53	NULL
,	NULL
54	NULL
)	NULL
;	NULL
by	NULL
using	NULL
Th1	NULL
and	NULL
Th2	NULL
CD4	NULL
*	NULL
T-cell	NULL
clones	NULL
,	NULL
no	NULL
differences	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
NFAT	NULL
were	NULL
observed	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
here	NULL
that	NULL
NFAT	NULL
is	NULL
regulated	NULL
similarly	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
pTh	NULL
cells	NULL
into	NULL
either	NULL
eTh1	NULL
or	NULL
eTh2	NULL
cells	NULL
.	NULL

During	NULL
this	NULL
process	NULL
,	NULL
NFAT	NULL
probably	NULL
mediates	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
,	NULL
which	NULL
is	NULL
induced	NULL
during	NULL
the	NULL
activation	NULL
of	NULL
pTh	NULL
cells	NULL
and	NULL
is	NULL
the	NULL
main	NULL
growth	NULL
factor	NULL
driving	NULL
T-cell	NULL
proliferation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
once	NULL
the	NULL
cells	NULL
have	NULL
differentiated	NULL
into	NULL
eTh1	NULL
or	NULL
eTh2	NULL
cells	NULL
,	NULL
NFAT	NULL
tran	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

scriptional	NULL
activity	NULL
can	NULL
be	NULL
induced	NULL
only	NULL
after	NULL
the	NULL
stimulation	NULL
of	NULL
eTh2	NULL
cells	NULL
,	NULL
but	NULL
to	NULL
a	NULL
much	NULL
lesser	NULL
extent	NULL
in	NULL
stimulated	NULL
eTh1	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
NFAT	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
Th2-type	NULL
cytokines	NULL
but	NULL
that	NULL
it	NULL
is	NULL
less	NULL
important	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
-type	NULL
cytokines	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
NFAT	NULL
regulatory	NULL
elements	NULL
which	NULL
are	NULL
secreted	NULL
by	NULL
eTh2	NULL
cells	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
IL-4	NULL
(	NULL
6	NULL
,	NULL
9	NULL
,	NULL
62	NULL
,	NULL
64	NULL
)	NULL
and	NULL
IL-5	NULL
(	NULL
42	NULL
)	NULL
genes	NULL
.	NULL

No	NULL
NFAT	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
described	NULL
yet	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
predominant	NULL
Th1	NULL
cytokine	NULL
,	NULL
IFN-y	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Since	NULL
IL-2	NULL
is	NULL
produced	NULL
by	NULL
Th1	NULL
clones	NULL
and	NULL
it	NULL
is	NULL
considered	NULL
a	NULL
Th1	NULL
cytokine	NULL
,	NULL
superficially	NULL
NFAT	NULL
should	NULL
be	NULL
expected	NULL
to	NULL
be	NULL
functional	NULL
in	NULL
eTh1	NULL
cells	NULL
.	NULL

We	NULL
did	NULL
not	NULL
,	NULL
however	NULL
,	NULL
find	NULL
production	NULL
of	NULL
large	NULL
amounts	NULL
of	NULL
IL-2	NULL
or	NULL
IL-2	NULL
mRNA	NULL
upon	NULL
stimulation	NULL
of	NULL
freshly	NULL
differentiated	NULL
eTh1	NULL
cells	NULL
by	NULL
quantitative	NULL
reverse	NULL
transcriptase	NULL
PCR	NULL
assays	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
Th1	NULL
T-cell	NULL
clones	NULL
make	NULL
IL-2	NULL
because	NULL
this	NULL
is	NULL
required	NULL
for	NULL
their	NULL
continuing	NULL
proliferation	NULL
,	NULL
a	NULL
property	NULL
for	NULL
which	NULL
they	NULL
have	NULL
been	NULL
selected	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
eThl1	NULL
cells	NULL
no	NULL
longer	NULL
need	NULL
to	NULL
proliferate	NULL
to	NULL
such	NULL
a	NULL
degree	NULL
after	NULL
differentiation	NULL
has	NULL
occurred	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
Th1	NULL
clones	NULL
has	NULL
been	NULL
described	NULL
to	NULL
require	NULL
more	NULL
costimulation	NULL
than	NULL
the	NULL
activation	NULL
of	NULL
Th2	NULL
clones	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
costimulation	NULL
during	NULL
the	NULL
activation	NULL
of	NULL
eTh1	NULL
cells	NULL
is	NULL
cause	NULL
for	NULL
the	NULL
lack	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
our	NULL
data	NULL
showed	NULL
that	NULL
the	NULL
provision	NULL
of	NULL
a	NULL
source	NULL
of	NULL
costimulation	NULL
by	NULL
APC	NULL
does	NULL
not	NULL
restore	NULL
the	NULL
induction	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
eTh1	NULL
cells	NULL
.	NULL

There	NULL
was	NULL
only	NULL
low	NULL
transcription	NULL
mediated	NULL
by	NULL
NFAT	NULL
in	NULL
eTh1	NULL
cells	NULL
,	NULL
which	NULL
may	NULL
account	NULL
for	NULL
the	NULL
lack	NULL
of	NULL
expression	NULL
of	NULL
specific	NULL
Th2	NULL
cytokines	NULL
whose	NULL
promoters	NULL
contain	NULL
such	NULL
NFAT	NULL
sites	NULL
.	NULL

This	NULL
nonetheless	NULL
begs	NULL
the	NULL
question	NULL
of	NULL
how	NULL
NFAT	NULL
is	NULL
functional	NULL
in	NULL
eTh2	NULL
cells	NULL
but	NULL
to	NULL
a	NULL
considerably	NULL
lesser	NULL
extent	NULL
in	NULL
eTh1	NULL
cells	NULL
.	NULL

There	NULL
are	NULL
several	NULL
possible	NULL
explanations	NULL
.	NULL

First	NULL
,	NULL
some	NULL
of	NULL
the	NULL
NFAT	NULL
members	NULL
might	NULL
be	NULL
expressed	NULL
only	NULL
in	NULL
eTh2	NULL
cells	NULL
,	NULL
or	NULL
since	NULL
NFAT	NULL
proteins	NULL
have	NULL
a	NULL
cytoplasmic	NULL
localization	NULL
and	NULL
need	NULL
to	NULL
be	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
they	NULL
might	NULL
fail	NULL
to	NULL
be	NULL
translocated	NULL
.	NULL

The	NULL
analysis	NULL
of	NULL
NFAT	NULL
DNA	NULL
binding	NULL
,	NULL
using	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
IL-2	NULL
promoter	NULL
and	NULL
one	NULL
of	NULL
the	NULL
sites	NULL
from	NULL
the	NULL
IL-4	NULL
promoter	NULL
(	NULL
from	NULL
=60	NULL
to	NULL
-83	NULL
or	NULL
from	NULL
=60	NULL
to	NULL
-91	NULL
)	NULL
,	NULL
demonstrated	NULL
,	NULL
however	NULL
,	NULL
that	NULL
both	NULL
NFATc	NULL
and	NULL
NFATp	NULL
members	NULL
were	NULL
present	NULL
,	NULL
could	NULL
be	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
bound	NULL
DNA	NULL
in	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
transcriptional	NULL
activity	NULL
induced	NULL
in	NULL
eTh2	NULL
cells	NULL
is	NULL
not	NULL
a	NULL
consequence	NULL
of	NULL
an	NULL
overexpression	NULL
of	NULL
specific	NULL
NFAT	NULL
proteins	NULL
.	NULL

A	NULL
second	NULL
potential	NULL
explanation	NULL
for	NULL
the	NULL
differential	NULL
induction	NULL
of	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
is	NULL
the	NULL
unique	NULL
presence	NULL
in	NULL
eTh2	NULL
cells	NULL
of	NULL
specifically	NULL
associated	NULL
cofactors	NULL
required	NULL
for	NULL
NFAT	NULL
to	NULL
mediate	NULL
transcription	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
Fos	NULL
and	NULL
Jun	NULL
protein	NULL
families	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
together	NULL
with	NULL
NFAT	NULL
proteins	NULL
,	NULL
and	NULL
this	NULL
cooperation	NULL
is	NULL
required	NULL
for	NULL
stable	NULL
binding	NULL
of	NULL
NFAT	NULL
and	NULL
to	NULL
mediate	NULL
transcription	NULL
through	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
(	NULL
4	NULL
,	NULL
27	NULL
,	NULL
44	NULL
,	NULL
54	NULL
)	NULL
.	NULL

However	NULL
,	NULL
special	NULL
experimental	NULL
conditions	NULL
are	NULL
required	NULL
to	NULL
detect	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
AP-1	NULL
component	NULL
present	NULL
in	NULL
the	NULL
NFAT	NULL
complex	NULL
(	NULL
27	NULL
,	NULL
53	NULL
)	NULL
,	NULL
it	NULL
is	NULL
not	NULL
totally	NULL
clear	NULL
which	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
member	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
complex	NULL
in	NULL
vivo	NULL
and	NULL
mediates	NULL
transcription	NULL
,	NULL
and	NULL
most	NULL
experiments	NULL
have	NULL
been	NULL
done	NULL
with	NULL
recombinant	NULL
proteins	NULL
.	NULL

In	NULL
our	NULL
hands	NULL
,	NULL
unlabeled	NULL
AP-1	NULL
oligonucleotide	NULL
completely	NULL
failed	NULL
to	NULL
compete	NULL
the	NULL
strong	NULL
binding	NULL
of	NULL
the	NULL
NFAT	NULL
c	NULL
and	NULL
NFAT	NULL
p	NULL
present	NULL
in	NULL
extracts	NULL
from	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
,	NULL
even	NULL
when	NULL
we	NULL
used	NULL
the	NULL
longer	NULL
NFAT	NULL
binding	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
AP-1/	NULL
Oct-like	NULL
site	NULL
(	NULL
54	NULL
)	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
antiserum	NULL
against	NULL
different	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
did	NULL
not	NULL
inhibit	NULL
NFAT	NULL
DNA	NULL
binding	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
AP-1	NULL
was	NULL
not	NULL
required	NULL
for	NULL
NFAT	NULL
DNA	NULL
binding	NULL
under	NULL
our	NULL
condi-tions	NULL
.	NULL

Despite	NULL
our	NULL
negative	NULL
results	NULL
,	NULL
we	NULL
can	NULL
not	NULL
eliminate	NULL
the	NULL
possibility	NULL
that	NULL
some	NULL
AP-1	NULL
components	NULL
,	NULL
which	NULL
might	NULL
not	NULL
be	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
under	NULL
our	NULL
conditions	NULL
but	NULL
are	NULL
required	NULL
for	NULL
NFAT	NULL
to	NULL
mediate	NULL
transcription	NULL
,	NULL
are	NULL
expressed	NULL
selectively	NULL
in	NULL
eTh2	NULL
cells	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
by	NULL
using	NULL
AP-1-luciferase	NULL
transgenic	NULL
mice	NULL
that	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
is	NULL
induced	NULL
in	NULL
eTh2	NULL
cells	NULL
but	NULL
to	NULL
a	NULL
much	NULL
lesser	NULL
extent	NULL
in	NULL
eTh1	NULL
cells	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
(	NULL
50	NULL
)	NULL
that	NULL
eTh2	NULL
but	NULL
not	NULL
eTh1	NULL
cells	NULL
overexpress	NULL
JunB	NULL
and	NULL
contain	NULL
JunB	NULL
complexes	NULL
,	NULL
which	NULL
bind	NULL
to	NULL
the	NULL
AP-1	NULL
regulatory	NULL
element	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
correlation	NULL
with	NULL
our	NULL
findings	NULL
,	NULL
all	NULL
previous	NULL
studies	NULL
done	NULL
to	NULL
identify	NULL
the	NULL
AP-1	NULL
components	NULL
required	NULL
for	NULL
NFAT	NULL
activity	NULL
describe	NULL
JunB	NULL
as	NULL
the	NULL
principal	NULL
Jun	NULL
family	NULL
member	NULL
present	NULL
in	NULL
the	NULL
NFAT	NULL
complexes	NULL
(	NULL
4	NULL
,	NULL
44	NULL
,	NULL
54	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
AP-1	NULL
contributes	NULL
to	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
Th2	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
reporter	NULL
transgenic	NULL
mice	NULL
where	NULL
the	NULL
luciferase	NULL
gene	NULL
was	NULL
driven	NULL
by	NULL
the	NULL
short	NULL
NFAT	NULL
regulatory	NULL
site	NULL
(	NULL
lacking	NULL
the	NULL
AP-1/Oct-like	NULL
site	NULL
)	NULL
from	NULL
the	NULL
IL-4	NULL
promoter	NULL
,	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
is	NULL
also	NULL
preferentially	NULL
induced	NULL
in	NULL
eTh2	NULL
cells	NULL
(	NULL
2a	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
both	NULL
NFAT	NULL
and	NULL
AP-1	NULL
contribute	NULL
to	NULL
selective	NULL
expression	NULL
in	NULL
eTh2	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
third	NULL
and	NULL
interesting	NULL
possibility	NULL
is	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
dephosphorylation	NULL
of	NULL
NFAT	NULL
that	NULL
causes	NULL
the	NULL
translocation	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
further	NULL
phosphorylation	NULL
of	NULL
the	NULL
transactivation	NULL
domain	NULL
is	NULL
required	NULL
to	NULL
mediate	NULL
transcription	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
mechanism	NULL
whereby	NULL
other	NULL
transcriptional	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
CREB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
some	NULL
of	NULL
the	NULL
STAT	NULL
members	NULL
,	NULL
are	NULL
activated	NULL
(	NULL
20	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Although	NULL
no	NULL
phosphorylation	NULL
requirement	NULL
for	NULL
NFAT	NULL
activity	NULL
has	NULL
been	NULL
described	NULL
,	NULL
this	NULL
potential	NULL
postranslational	NULL
modification	NULL
of	NULL
the	NULL
NFAT	NULL
component	NULL
could	NULL
be	NULL
a	NULL
specific	NULL
characteristic	NULL
of	NULL
eTh2	NULL
cells	NULL
.	NULL

No	NULL
differences	NULL
in	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
NFAT	NULL
complexes	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
from	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
were	NULL
observed	NULL
.	NULL

In	NULL
most	NULL
experiments	NULL
the	NULL
level	NULL
of	NULL
NFAT	NULL
complexes	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
was	NULL
equivalent	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
a	NULL
slightly	NULL
(	NULL
1.5-to	NULL
2-fold	NULL
)	NULL
greater	NULL
level	NULL
of	NULL
NFAT	NULL
complexes	NULL
were	NULL
observed	NULL
in	NULL
Th2	NULL
cells	NULL
,	NULL
and	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
a	NULL
small	NULL
difference	NULL
like	NULL
this	NULL
explains	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
the	NULL
Th2/Th1l	NULL
difference	NULL
in	NULL
NFAT	NULL
activity	NULL
.	NULL

It	NULL
is	NULL
striking	NULL
that	NULL
NFATp	NULL
(	NULL
upper	NULL
component	NULL
)	NULL
was	NULL
induced	NULL
in	NULL
pTh	NULL
cells	NULL
and	NULL
remained	NULL
present	NULL
in	NULL
unstimulated	NULL
eTh	NULL
cells	NULL
,	NULL
while	NULL
the	NULL
NFAT	NULL
binding	NULL
(	NULL
lower	NULL
component	NULL
)	NULL
is	NULL
induced	NULL
in	NULL
eTh	NULL
cells	NULL
only	NULL
upon	NULL
stimulation	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
NFATe	NULL
probably	NULL
mediates	NULL
the	NULL
transcription	NULL
of	NULL
effector	NULL
molecules	NULL
in	NULL
eTh2	NULL
cells	NULL
,	NULL
while	NULL
NFATp	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
precursor	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
observation	NULL
correlates	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
NFATp-deficient	NULL
mice	NULL
do	NULL
not	NULL
show	NULL
significant	NULL
differences	NULL
in	NULL
effector	NULL
cytokine	NULL
levels	NULL
(	NULL
TNF-a	NULL
,	NULL
IFN	NULL
,	NULL
or	NULL
IL-4	NULL
)	NULL
but	NULL
increased	NULL
proliferation	NULL
in	NULL
vitro	NULL
in	NULL
response	NULL
to	NULL
Leishmania	NULL
major	NULL
was	NULL
observed	NULL
(	NULL
68	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
seems	NULL
that	NULL
NFATp-deficient	NULL
mice	NULL
show	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
predictions	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
production	NULL
of	NULL
IL-4	NULL
in	NULL
response	NULL
to	NULL
anti-CD3	NULL
MAb	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Future	NULL
studies	NULL
will	NULL
be	NULL
needed	NULL
to	NULL
determine	NULL
the	NULL
NFAT	NULL
transcriptional	NULL
activity	NULL
in	NULL
eTh2	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
NFATp	NULL
component	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
indicate	NULL
that	NULL
although	NULL
NFAT	NULL
proteins	NULL
are	NULL
present	NULL
and	NULL
able	NULL
to	NULL
bind	NULL
DNA	NULL
in	NULL
both	NULL
eTh1	NULL
and	NULL
eTh2	NULL
cells	NULL
,	NULL
they	NULL
are	NULL
mainly	NULL
transcriptionally	NULL
functional	NULL
in	NULL
stimulated	NULL
eTh2	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
NFAT	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
expression	NULL
of	NULL
eTh2	NULL
specific	NULL
effector	NULL
molecules	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
low	NULL
level	NULL
of	NULL
NFAT-mediated	NULL
transcription	NULL
in	NULL
eTh1	NULL
cells	NULL
is	NULL
probably	NULL
in	NULL
part	NULL
the	NULL
cause	NULL
of	NULL
the	NULL
inability	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
express	NULL
IL-4	NULL
.	NULL

This	NULL
information	NULL
could	NULL
be	NULL
relevant	NULL
in	NULL
the	NULL
search	NULL
to	NULL
contain	NULL
infections	NULL
or	NULL
autoimmune	NULL
diseases	NULL
,	NULL
where	NULL
the	NULL
polarization	NULL
to	NULL
an	NULL
eTh1	NULL
or	NULL
eTh2	NULL
immune	NULL
response	NULL
determines	NULL
the	NULL
grade	NULL
or	NULL
susceptibility	NULL
of	NULL
resistance	NULL
to	NULL
a	NULL
particular	NULL
pathogen	NULL
and	NULL
the	NULL
course	NULL
of	NULL
autoimmune	NULL
pathogenesis	NULL
.	NULL

NFAT	NULL
TRANSCRIPTIONAL	NULL
ACTIVITY	NULL
IN	NULL
CD4+*	NULL
Th2	NULL
CELLS	NULL
|	NULL
1533	NULL
ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Genetics	NULL
Institute	NULL
for	NULL
a	NULL
gift	NULL
of	NULL
IL-12	NULL
and	NULL
DNAX	NULL
for	NULL
IL-4	NULL
.	NULL

We	NULL
thank	NULL
C.	NULL
Hughes	NULL
and	NULL
D.	NULL
Butkus	NULL
for	NULL
generating	NULL
the	NULL
NFAT-Luc	NULL
transgenic	NULL
mice	NULL
,	NULL
S.	NULL
Hedrick	NULL
for	NULL
providing	NULL
the	NULL
Cyt	NULL
c	NULL
TCR	NULL
transgenic	NULL
mice	NULL
,	NULL
L.	NULL
Timmerman	NULL
and	NULL
G.	NULL
Crabtree	NULL
for	NULL
the	NULL
NFAT-Luc	NULL
construct	NULL
and	NULL
helpful	NULL
advice	NULL
,	NULL
and	NULL
F.	NULL
Manzo	NULL
for	NULL
secretarial	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
NIH	NULL
grant	NULL
1	NULL
RO1	NULL
AI29902	NULL
.	NULL

R.A.F	NULL
.	NULL

is	NULL
an	NULL
investigator	NULL
of	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Imagawa	NULL
,	NULL
R.	NULL
Chiu	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
R.	NULL
J.	NULL
Imbra	NULL
,	NULL
H.	NULL
J.	NULL
Rahmsdorf	NULL
,	NULL
C.	NULL
Jonat	NULL
,	NULL
P.	NULL
Herrlich	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1987	NULL
.	NULL

Phorbol	NULL
ester-inducible	NULL
genes	NULL
contain	NULL
a	NULL
common	NULL
cis	NULL
element	NULL
recognized	NULL
by	NULL
a	NULL
TPA-modulated	NULL
trans-acting	NULL
factor	NULL
.	NULL

Cell	NULL
49:729-739	NULL
.	NULL

2	NULL
.	NULL

Aramburu	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Azzoni	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
B.	NULL
Perussia	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
nuclear	NULL
factors	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
NFATp	NULL
and	NULL
NFATc	NULL
,	NULL
in	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
:	NULL
regulation	NULL
upon	NULL
CD16	NULL
ligand	NULL
binding	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:801-810	NULL
.	NULL

2a	NULL
.	NULL

Aune	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

3	NULL
.	NULL

Azuma	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Ito	NULL
,	NULL
H.	NULL
Yagita	NULL
,	NULL
K.	NULL
Okumura	NULL
,	NULL
J.	NULL
H.	NULL
Phillips	NULL
,	NULL
L.	NULL
Lanier	NULL
,	NULL
and	NULL
C.	NULL
Somoza	NULL
.	NULL

1993	NULL
.	NULL

B70	NULL
antigen	NULL
is	NULL
a	NULL
second	NULL
ligand	NULL
for	NULL
CTLA-4	NULL
and	NULL
CD28	NULL
.	NULL

Nature	NULL
366:76-79	NULL
.	NULL

4	NULL
.	NULL

Boise	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
B.	NULL
Petrynyak	NULL
,	NULL
X.	NULL
Mao	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kovary	NULL
,	NULL
J.	NULL
M.	NULL
Leiden	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NFAT-1	NULL
DNA	NULL
binding	NULL
complex	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fra-1	NULL
and	NULL
JunB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1911-1919	NULL
.	NULL

5	NULL
.	NULL

Bretscher	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
G.	NULL
Wei	NULL
,	NULL
J.	NULL
N.	NULL
Menon	NULL
,	NULL
and	NULL
H.	NULL
Bielefeldt-Ohmann	NULL
.	NULL

1992	NULL
.	NULL

Establishment	NULL
of	NULL
stable	NULL
,	NULL
cell-mediated	NULL
immunity	NULL
that	NULL
makes	NULL
``	NULL
susceptible	NULL
``	NULL
mice	NULL
resistant	NULL
to	NULL
Leishmania	NULL
major	NULL
.	NULL

Science	NULL
257:539-542	NULL
.	NULL

6	NULL
.	NULL

Bruhn	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
K.	NULL
Nelms	NULL
,	NULL
J.	NULL
L.	NULL
Boulay	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
dissection	NULL
of	NULL
the	NULL
mouse	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:9707-9711	NULL
.	NULL

7	NULL
.	NULL

Chen	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
E.	NULL
V.	NULL
Rothenberg	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
basis	NULL
for	NULL
developmental	NULL
changes	NULL
in	NULL
interleukin-2	NULL
gene	NULL
inducibility	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:228-237	NULL
.	NULL

8	NULL
.	NULL

Choi	NULL
,	NULL
M.	NULL
S.	NULL
K.	NULL
,	NULL
R.	NULL
D.	NULL
Brines	NULL
,	NULL
M.	NULL
J.	NULL
Holman	NULL
,	NULL
and	NULL
G.	NULL
G.	NULL
B.	NULL
Klaus	NULL
.	NULL

1994	NULL
.	NULL

Induction	NULL
of	NULL
NF-AT	NULL
in	NULL
normal	NULL
B	NULL
lymphocytes	NULL
by	NULL
anti-immunoglobulin	NULL
or	NULL
CD40	NULL
ligand	NULL
in	NULL
conjunction	NULL
with	NULL
IL-4	NULL
.	NULL

Immunity	NULL
1:179-187	NULL
.	NULL

9	NULL
.	NULL

Chuypilo	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Schomberg	NULL
,	NULL
R.	NULL
Gerwing	NULL
,	NULL
A.	NULL
Heinfling	NULL
,	NULL
R.	NULL
Reeves	NULL
,	NULL
F.	NULL
Grummt	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1993	NULL
.	NULL

Multiple	NULL
closely-linked	NULL
NFAT/octamer	NULL
and	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
sites	NULL
are	NULL
part	NULL
of	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:5694-5704	NULL
.	NULL

10	NULL
.	NULL

Clipstone	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
calcineurin	NULL
as	NULL
a	NULL
key	NULL
signaling	NULL
enzyme	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Nature	NULL
357:695-697	NULL
.	NULL

11	NULL
.	NULL

Constant	NULL
,	NULL
S.	NULL
,	NULL
C.	NULL
Pfeiffer	NULL
,	NULL
A.	NULL
Woodard	NULL
,	NULL
T.	NULL
Pasqualini	NULL
,	NULL
and	NULL
K.	NULL
Bottomly	NULL
.	NULL

1995	NULL
.	NULL

Extent	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
ligation	NULL
can	NULL
determine	NULL
the	NULL
functional	NULL
differentiation	NULL
of	NULL
naive	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:1591-1596	NULL
.	NULL

12	NULL
.	NULL

Croft	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
M.	NULL
Bradley	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Swain	NULL
.	NULL

1994	NULL
.	NULL

Naive	NULL
versus	NULL
memory	NULL
CD4	NULL
T	NULL
cell	NULL
response	NULL
to	NULL
antigen	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:2675-2685	NULL
.	NULL

13	NULL
.	NULL

Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
J.	NULL
P.	NULL
Shaw	NULL
,	NULL
M.	NULL
R.	NULL
Bush	NULL
,	NULL
R.	NULL
E.	NULL
Replogle	NULL
,	NULL
R.	NULL
Belageje	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
antigen	NULL
receptor	NULL
response	NULL
elements	NULL
within	NULL
the	NULL
interleukin-2	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1715-1724	NULL
.	NULL

14	NULL
.	NULL

Emmel	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
C.	NULL
L.	NULL
Verweij	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
K.	NULL
M.	NULL
Higgins	NULL
,	NULL
E.	NULL
Lacy	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1989	NULL
.	NULL

Cyclosporin	NULL
A	NULL
specifically	NULL
inhibits	NULL
function	NULL
of	NULL
nuclear	NULL
proteins	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Science	NULL
246:1617-1620	NULL
.	NULL

15	NULL
.	NULL

Fiering	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
P.	NULL
Northrop	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
P.	NULL
S.	NULL
Mattila	NULL
,	NULL
G.	NULL
R.	NULL
Crabtree	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Herzenberg	NULL
,	NULL
1990	NULL
.	NULL

Single	NULL
cell	NULL
assay	NULL
of	NULL
a	NULL
transcription	NULL
factor	NULL
reveals	NULL
a	NULL
threshold	NULL
in	NULL
transcription	NULL
activated	NULL
by	NULL
signals	NULL
emanating	NULL
from	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1823-1834	NULL
.	NULL

16	NULL
.	NULL

Flanagan	NULL
,	NULL
W.	NULL
F.	NULL
,	NULL
B.	NULL
Corthesy	NULL
,	NULL
R.	NULL
J.	NULL
Bram	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1991	NULL
.	NULL

Nuclear	NULL
association	NULL
of	NULL
a	NULL
T-cell	NULL
transcription	NULL
factor	NULL
blocked	NULL
by	NULL
FK-506	NULL
and	NULL
cyclosporin	NULL
A	NULL
.	NULL

Nature	NULL
352:803-807	NULL
.	NULL

17	NULL
.	NULL

Freeman	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
F.	NULL
Borriello	NULL
,	NULL
R.	NULL
J.	NULL
Hodes	NULL
,	NULL
H.	NULL
Reiser	NULL
,	NULL
J.	NULL
G.	NULL
Gribben	NULL
,	NULL
J.	NULL
W.	NULL
Ng	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
J.	NULL
M.	NULL
Goldberg	NULL
,	NULL
K.	NULL
Hathcock	NULL
,	NULL
G.	NULL
Laszlo	NULL
,	NULL
L.	NULL
A.	NULL
Lombard	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
G.	NULL
S.	NULL
Gray	NULL
,	NULL
L.	NULL
M.	NULL
Nadler	NULL
,	NULL
and	NULL
A.	NULL
H.	NULL
Sharpe	NULL
.	NULL

1993	NULL
.	NULL

Murine	NULL
B7-2	NULL
,	NULL
an	NULL
alternative	NULL
CTLA4	NULL
counter-receptor	NULL
that	NULL
costimulates	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
interleukin	NULL
2	NULL
production	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:2185-2192	NULL
.	NULL

18	NULL
.	NULL

Freeman	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
A.	NULL
S.	NULL
Freedman	NULL
,	NULL
J.	NULL
M.	NULL
Segil	NULL
,	NULL
G.	NULL
Lee	NULL
,	NULL
J.	NULL
L.	NULL
Whitman	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Nadler	NULL
.	NULL

1989	NULL
.	NULL

B7	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
Ig	NULL
superfamily	NULL
with	NULL
unique	NULL
expression	NULL
on	NULL
activated	NULL
and	NULL
neoplastic	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:2714-2722	NULL
.	NULL

19	NULL
.	NULL

Gillis	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
N.	NULL
Ferm	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Smith	NULL
.	NULL

1978	NULL
.	NULL

T	NULL
cell	NULL
growth	NULL
factor	NULL
:	NULL
parameters	NULL
of	NULL
production	NULL
and	NULL
quantitative	NULL
microassay	NULL
for	NULL
activity	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

120:1109-1113	NULL
.	NULL

20	NULL
.	NULL

Gonzalez	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
P.	NULL
Menzel	NULL
,	NULL
J.	NULL
Leonard	NULL
,	NULL
W.	NULL
H.	NULL
Fischer	NULL
,	NULL
and	NULL
M.	NULL
Montminy	NULL
.	NULL

1991	NULL
.	NULL

Characterization	NULL
of	NULL
motifs	NULL
which	NULL
are	NULL
critical	NULL
for	NULL
activity	NULL
of	NULL
the	NULL
cyclic	NULL
AMP-responsive	NULL
transcription	NULL
factor	NULL
CREB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:1306-1312	NULL
.	NULL

21	NULL
.	NULL

Ho	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
X.	NULL
Li	NULL
,	NULL
U.	NULL
Francke	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1995	NULL
.	NULL

NFATc3	NULL
,	NULL
a	NULL
lymphoid-specific	NULL
NFATc	NULL
family	NULL
member	NULL
that	NULL
is	NULL
calcium-regulated	NULL
and	NULL
exhibits	NULL
distinct	NULL
DNA	NULL
binding	NULL
specificity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:19898-19907	NULL
.	NULL

22	NULL
.	NULL

Hodge	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
A.	NULL
M.	NULL
Ranger	NULL
,	NULL
F.	NULL
Charles	NULL
de	NULL
la	NULL
Brousse	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
J.	NULL
Grusby	NULL
,	NULL
1534	NULL
23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

RINCON	NULL
AND	NULL
FLAVELL	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1996	NULL
.	NULL

Hyperproliferation	NULL
and	NULL
dysregulation	NULL
of	NULL
IL-4	NULL
expression	NULL
in	NULL
NF-ATp-deficient	NULL
mice	NULL
.	NULL

Immunity	NULL
4:397-405	NULL
.	NULL

Hoey	NULL
,	NULL
T.	NULL
,	NULL
Y.-L.	NULL
Sun	NULL
,	NULL
K.	NULL
Williamson	NULL
,	NULL
and	NULL
X.	NULL
Xiang	NULL
.	NULL

1995	NULL
.	NULL

Isolation	NULL
of	NULL
two	NULL
new	NULL
members	NULL
of	NULL
the	NULL
NFAT	NULL
gene	NULL
family	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
NFAT	NULL
proteins	NULL
.	NULL

Immunity	NULL
2461-472	NULL
.	NULL

Hogan	NULL
,	NULL
B.	NULL
,	NULL
F.	NULL
Constantini	NULL
,	NULL
and	NULL
E.	NULL
Lacy	NULL
.	NULL

1986	NULL
.	NULL

Manipulating	NULL
the	NULL
mouse	NULL
embryo	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
.	NULL

Hsieh	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
S.	NULL
E.	NULL
Macatonia	NULL
,	NULL
C.	NULL
S.	NULL
Tripp	NULL
,	NULL
S.	NULL
F.	NULL
Wolf	NULL
,	NULL
A.	NULL
O'Garra	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1993	NULL
.	NULL

Development	NULL
of	NULL
Thi	NULL
CD4*	NULL
T	NULL
cells	NULL
through	NULL
IL-12	NULL
produced	NULL
by	NULL
Listeria-induced	NULL
macrophages	NULL
.	NULL

Science	NULL
260:547-549	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
A	NULL
.	NULL

Miner	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
J.	NULL
N.	NULL
Lambert	NULL
,	NULL
G.	NULL
L.	NULL
Verdine	NULL
,	NULL
T.	NULL
Curram	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
T-cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
calcineurin	NULL
and	NULL
interacts	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
365:352-355	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
V.	NULL
E.	NULL
Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
356:801-804	NULL
.	NULL

Jenkins	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1987	NULL
.	NULL

Antigen	NULL
presentation	NULL
by	NULL
chemical	NULL
modified	NULL
splenocytes	NULL
induces	NULL
antigen-specific	NULL
T	NULL
cell	NULL
unresponsiveness	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165:302	NULL
.	NULL

Kamogawa	NULL
,	NULL
Y.	NULL
,	NULL
L.-A	NULL
.	NULL

E.	NULL
Minasi	NULL
,	NULL
S.	NULL
Carding	NULL
,	NULL
K.	NULL
Bottomly	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
relationship	NULL
of	NULL
IL-4	NULL
and	NULL
IFNy-producing	NULL
T	NULL
cells	NULL
studied	NULL
by	NULL
lincage	NULL
ablation	NULL
of	NULL
IL-4-producing	NULL
cells	NULL
.	NULL

Cell	NULL
75:985-995	NULL
.	NULL

Kaye	NULL
,	NULL
J.	NULL
,	NULL
M.-L.	NULL
Hsu	NULL
,	NULL
M.-E.	NULL
Sauron	NULL
,	NULL
S.	NULL
C.	NULL
Jameson	NULL
,	NULL
N.	NULL
R.	NULL
J.	NULL
Gascoigne	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Hedrick	NULL
.	NULL

1989	NULL
.	NULL

Selective	NULL
development	NULL
of	NULL
CD4+	NULL
T	NULL
cells	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
class	NULL
II	NULL
MHC-restricted	NULL
antigen	NULL
receptor	NULL
.	NULL

Nature	NULL
341:746-749	NULL
.	NULL

Kuchroo	NULL
,	NULL
V.	NULL
K.	NULL
,	NULL
M.	NULL
Prabhu	NULL
Das	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Brown	NULL
,	NULL
A.	NULL
M.	NULL
Ranger	NULL
,	NULL
S.	NULL
S.	NULL
Zamvil	NULL
,	NULL
R.	NULL
A.	NULL
Sobel	NULL
,	NULL
H.	NULL
L.	NULL
Weiner	NULL
,	NULL
N.	NULL
Nabavi	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1995	NULL
.	NULL

B7-1	NULL
and	NULL
B7-2	NULL
costimulatory	NULL
molecules	NULL
activate	NULL
differentially	NULL
the	NULL
Thi/Th2	NULL
developmental	NULL
pathways	NULL
:	NULL
application	NULL
to	NULL
autoimmune	NULL
disease	NULL
therapy	NULL
.	NULL

Cell	NULL
80:707-718	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
P.	NULL
Mitchell	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

Purified	NULL
transcription	NULL
factor	NULL
AP-1	NULL
interacts	NULL
with	NULL
TPA-inducible	NULL
enhancer	NULL
elements	NULL
.	NULL

Cell	NULL
49:741-752	NULL
.	NULL

Le	NULL
Gros	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Z.	NULL
Ben-Sasson	NULL
,	NULL
R.	NULL
Seder	NULL
,	NULL
F.	NULL
D.	NULL
Finkelman	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1990	NULL
.	NULL

Generation	NULL
of	NULL
interleukin	NULL
4	NULL
(	NULL
IL-4	NULL
)	NULL
-producing	NULL
cells	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitrol	NULL
:	NULL
IL-2	NULL
and	NULL
IL-4	NULL
are	NULL
required	NULL
for	NULL
in	NULL
vitro	NULL
generation	NULL
of	NULL
IL-4	NULL
producing	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:921-929	NULL
.	NULL

Lenschow	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
S.	NULL
C.	NULL
Ho	NULL
,	NULL
H.	NULL
Sattar	NULL
,	NULL
L.	NULL
Rhee	NULL
,	NULL
G.	NULL
Gray	NULL
,	NULL
N.	NULL
Nabavi	NULL
,	NULL
K.	NULL
C.	NULL
Herold	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
.	NULL

1995	NULL
.	NULL

Differential	NULL
effects	NULL
of	NULL
anti-B7-1	NULL
and	NULL
anti-B7-2	NULL
monoclonal	NULL
antibody	NULL
treatment	NULL
on	NULL
the	NULL
development	NULL
of	NULL
diabetes	NULL
in	NULL
the	NULL
nonobese	NULL
diabetic	NULL
mouse	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:1145-1155	NULL
.	NULL

Linsley	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
W.	NULL
Brady	NULL
,	NULL
L.	NULL
Grosmaire	NULL
,	NULL
A.	NULL
Aruffo	NULL
,	NULL
N.	NULL
K.	NULL
Damle	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
.	NULL

1991	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
activation	NULL
antigen	NULL
B7	NULL
to	NULL
CD28	NULL
costimulates	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
interleukin	NULL
2	NULL
mRNA	NULL
accumulation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:721-730	NULL
.	NULL

Linsley	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
CD28	NULL
receptor	NULL
during	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11:191-212	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
F.	NULL
Saito	NULL
,	NULL
C.	NULL
Hannum	NULL
,	NULL
K.-I	NULL
.	NULL

Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1995	NULL
.	NULL

NFATsz	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated-T-cell	NULL
family	NULL
that	NULL
is	NULL
predominantly	NULL
expressed	NULL
in	NULL
thymus	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2697-2707	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
A.	NULL
M.	NULL
Ho	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
J.	NULL
N.	NULL
Lambert	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
G.	NULL
L.	NULL
Verdine	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1993	NULL
.	NULL

Isolation	NULL
of	NULL
cyclosporin-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
.	NULL

Science	NULL
262:750-754	NULL
.	NULL

Montminy	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Bilezikijan	NULL
.	NULL

1986	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
protein	NULL
to	NULL
the	NULL
cyclic-AMP	NULL
response	NULL
element	NULL
of	NULL
the	NULL
somatostatin	NULL
gene	NULL
.	NULL

Nature	NULL
328:175-178	NULL
.	NULL

Mosman	NULL
Â»	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Coffman	NULL
.	NULL

1989	NULL
.	NULL

Thi	NULL
and	NULL
Th2	NULL
cells	NULL
:	NULL
different	NULL
patterns	NULL
of	NULL
lymphokine	NULL
secretion	NULL
lead	NULL
to	NULL
different	NULL
functional	NULL
properties	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

7:145-173	NULL
.	NULL

Mueller	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
M.	NULL
K.	NULL
Jenkins	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1989	NULL
.	NULL

Clonal	NULL
expansion	NULL
vs	NULL
functional	NULL
clonal	NULL
inactivation	NULL
:	NULL
a	NULL
costimulatory	NULL
pathway	NULL
determines	NULL
the	NULL
outcome	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
occupancy	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

7:445-480	NULL
.	NULL

41a	NULL
.	NULL

Nakamura	NULL
,	NULL
T.	NULL
Unpublished	NULL
data	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

Naora	NULL
,	NULL
H.	NULL
,	NULL
B.	NULL
H.	NULL
van	NULL
Leeuwen	NULL
,	NULL
P.	NULL
F.	NULL
Bourke	NULL
,	NULL
and	NULL
I.	NULL
G.	NULL
Young	NULL
.	NULL

1994	NULL
.	NULL

Functional	NULL
roles	NULL
and	NULL
signal-induced	NULL
modulation	NULL
of	NULL
proteins	NULL
recognizing	NULL
the	NULL
conserved	NULL
TCATTT-containing	NULL
promoter	NULL
elements	NULL
in	NULL
the	NULL
murine	NULL
IL-5	NULL
and	NULL
GM-CSF	NULL
genes	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:3466-3475	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1994	NULL
.	NULL

NF-AT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
369:497-502	NULL
.	NULL

Northrop	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
K.	NULL
S.	NULL
Ullman	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
components	NULL
of	NULL
the	NULL
lymphoid-specific	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:2917-2923	NULL
.	NULL

O'Keefe	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
J.	NULL
Tamura	NULL
,	NULL
R.	NULL
L.	NULL
Kincaid	NULL
,	NULL
M.	NULL
J.	NULL
Tocci	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
O'Neill	NULL
.	NULL

1992	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

FK506	NULL
and	NULL
cyclosporin	NULL
A-sensitive	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
by	NULL
calcineurin	NULL
.	NULL

Nature	NULL
357:692-694	NULL
.	NULL

Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Seder	NULL
.	NULL

1994	NULL
.	NULL

Lymphocyte	NULL
response	NULL
and	NULL
cytokines	NULL
.	NULL

Cell	NULL
76:241-251	NULL
.	NULL

Penix	NULL
,	NULL
L.	NULL
,	NULL
W.	NULL
M.	NULL
Weaver	NULL
,	NULL
Y.	NULL
Pang	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Wilson	NULL
.	NULL

1993	NULL
.	NULL

Two	NULL
essential	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
interferon	NULL
gamma	NULL
promoter	NULL
confer	NULL
activation	NULL
specific	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1483-1496	NULL
.	NULL

Pfeiffer	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
Stein	NULL
,	NULL
S.	NULL
Southwood	NULL
,	NULL
H.	NULL
Keterlaar	NULL
,	NULL
A.	NULL
Sette	NULL
,	NULL
and	NULL
K.	NULL
Bottomly	NULL
.	NULL

1995	NULL
.	NULL

Altered	NULL
peptide	NULL
ligands	NULL
can	NULL
control	NULL
CD4	NULL
T	NULL
lymphocyte	NULL
differentiation	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:1569-1574	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

1994	NULL
.	NULL

NF-ATp	NULL
:	NULL
a	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
the	NULL
co-ordinate	NULL
induction	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
15:274-281	NULL
.	NULL

Rincon	NULL
,	NULL
M.	NULL
,	NULL
B.	NULL
DÃ©rijard	NULL
,	NULL
C.-W.	NULL
Chow	NULL
,	NULL
R.	NULL
J.	NULL
Davis	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

Reprogramming	NULL
the	NULL
signaling	NULL
requirement	NULL
for	NULL
AP-1	NULL
activation	NULL
during	NULL
differentiation	NULL
of	NULL
precursor	NULL
CD4+	NULL
T	NULL
cells	NULL
to	NULL
effector	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
.	NULL

Genes	NULL
Funct	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

Rincon	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1994	NULL
.	NULL

AP-1	NULL
transcriptional	NULL
activity	NULL
requires	NULL
both	NULL
T-cell	NULL
receptor-mediated	NULL
and	NULL
co-stimulatory	NULL
signals	NULL
in	NULL
primary	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:4370-4381	NULL
.	NULL

Rincon	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
AP-1	NULL
and	NULL
NFAT	NULL
transcription	NULL
factors	NULL
during	NULL
thymic	NULL
selection	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1074-1084	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
M.	NULL
R.	NULL
Hodge	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
common	NULL
factor	NULL
regulates	NULL
both	NULL
Th1-	NULL
and	NULL
Th2-specific	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:625-633	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1995	NULL
.	NULL

Coordinate	NULL
and	NULL
cooperative	NULL
roles	NULL
for	NULL
NFAT	NULL
and	NULL
AP-1	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
murine	NULL
IL-4	NULL
gene	NULL
.	NULL

Immunity	NULL
2473-483	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Miller	NULL
,	NULL
and	NULL
W.	NULL
Shaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini'-extracts	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

Schreiber	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
K506	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
13:136-142	NULL
.	NULL

Seder	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
R.	NULL
Gazzinelli	NULL
,	NULL
A.	NULL
Sher	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1993	NULL
.	NULL

IL-12	NULL
acts	NULL
directly	NULL
on	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
to	NULL
enhance	NULL
priming	NULL
for	NULL
IFNy	NULL
production	NULL
and	NULL
diminish	NULL
IL-4	NULL
inhibition	NULL
of	NULL
such	NULL
priming	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:10188-10192	NULL
.	NULL

Serfling	NULL
,	NULL
E.	NULL
,	NULL
R.	NULL
Bsrthelmiis	NULL
,	NULL
I.	NULL
Pfeuffer	NULL
,	NULL
B.	NULL
Schenk	NULL
,	NULL
S.	NULL
Zarius	NULL
,	NULL
R.	NULL
Swoboda	NULL
,	NULL
F.	NULL
Mercurio	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1989	NULL
.	NULL

Ubiquitous	NULL
and	NULL
lymphocyte-specific	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
mouse	NULL
interleukin	NULL
2	NULL
gene	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:465-473	NULL
.	NULL

Shaw	NULL
,	NULL
J.-P.	NULL
,	NULL
P.	NULL
J.	NULL
Utz	NULL
,	NULL
D.	NULL
B.	NULL
Durand	NULL
,	NULL
J.	NULL
J.	NULL
Toole	NULL
,	NULL
E.	NULL
A.	NULL
Emmel	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
241:202-205	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
T.	NULL
Kallunki	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
77:727-736	NULL
.	NULL

Swain	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
A.	NULL
D.	NULL
Weinberg	NULL
,	NULL
M.	NULL
English	NULL
,	NULL
and	NULL
G.	NULL
Huston	NULL
.	NULL

1990	NULL
.	NULL

IL-4	NULL
directs	NULL
the	NULL
development	NULL
of	NULL
Th2-like	NULL
helper	NULL
effectors	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:3796-3806	NULL
.	NULL

Szabo	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
J.	NULL
S.	NULL
Gold	NULL
,	NULL
T.	NULL
L.	NULL
Murphy	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
controlling	NULL
interleukin-4	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
roles	NULL
for	NULL
NF-Y	NULL
and	NULL
NF-ATc	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4793-4805	NULL
.	NULL

Tara	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
L.	NULL
Weiss	NULL
,	NULL
and	NULL
M.	NULL
A	NULL
.	NULL

Brown	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
constitutive	NULL
and	NULL
inducible	NULL
components	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
IL-4	NULL
activation	NULL
responsive	NULL
clement	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:4592-4602	NULL
.	NULL

Todd	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
M.	NULL
J.	NULL
Grusby	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Lederer	NULL
,	NULL
E.	NULL
L.	NULL
Lacy	NULL
,	NULL
A.	NULL
H.	NULL
Lichtman	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1993	NULL
.	NULL

Transcription	NULL
of	NULL
interleukin-4	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
multiple	NULL
promoter	NULL
elements	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:1663-1674	NULL
.	NULL

Tugores	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
A.	NULL
Alonso	NULL
,	NULL
F.	NULL
Sanchez-Madrid	NULL
,	NULL
and	NULL
M.	NULL
O.	NULL
de	NULL
1992	NULL
.	NULL

Human	NULL
T	NULL
cell	NULL
activation	NULL
through	NULL
the	NULL
activation-inducer	NULL
molecule/	NULL
CD69	NULL
enhances	NULL
the	NULL
activity	NULL
of	NULL
transcription	NULL
factor	NULL
AP-1	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148	NULL
:	NULL
2300-2306	NULL
.	NULL

Venkataraman	NULL
,	NULL
L.	NULL
,	NULL
D.	NULL
Francis	NULL
,	NULL
Z.	NULL
Wang	NULL
,	NULL
J.	NULL
Liu	NULL
,	NULL
T.	NULL
L.	NULL
Rothstein	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1994	NULL
.	NULL

Cyclosporin-A	NULL
sensitive	NULL
induction	NULL
of	NULL
NFAT	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

Immunity	NULL
1:189-196	NULL
.	NULL

Verweij	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
C.	NULL
Guidos	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1990	NULL
.	NULL

Cell	NULL
type	NULL
specificity	NULL
and	NULL
activation	NULL
requirements	NULL
for	NULL
NFAT-1	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T-cells	NULL
)	NULL
transcriptional	NULL
activity	NULL
determined	NULL
by	NULL
a	NULL
new	NULL
method	NULL
using	NULL
transgenic	NULL
mice	NULL
to	NULL
assay	NULL
transcriptional	NULL
activity	NULL
of	NULL
an	NULL
individual	NULL
nuclear	NULL
factor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:15788-15795	NULL
.	NULL

Xanthoudakis	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
P.	NULL
B.	NULL
Viola	NULL
,	NULL
K.	NULL
T.	NULL
Y.	NULL
Shaw	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
J.	NULL
D.	NULL
Wallace	NULL
,	NULL
P.	NULL
T.	NULL
Bozza	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
enhanced	NULL
immune	NULL
response	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT1	NULL
.	NULL

Science	NULL
272:892-895	NULL
.	NULL

Yaseen	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
A.	NULL
L.	NULL
Maizel	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
S.	NULL
Sharma	NULL
.	NULL

1993	NULL
.	NULL

Comparative	NULL
analysis	NULL
of	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
complex	NULL
in	NULL
human	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:14285-14293	NULL
.	NULL

